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 Cardiovascular complications involving both microvascular and macrovascular tissues 
are the major cause of morbidity and mortality in obese patients. Clinical and epidemiological 
studies suggest that erectile dysfunction and peripheral endothelial dysfunction may predict 
cardiovascular risk. The purpose of these studies was to investigate NADPH oxidase, a major 
source of vascular derived oxidative stress, as a common mechanism between erectile 
dysfunction and coronary artery endothelial dysfunction in rats fed a Western diet (WD), and 
peripheral endothelial dysfunction in an obese group of human subjects. Male Sprague-Dawley 
rats were fed a control diet (CD) or WD for 4, 8, or 12 weeks. Erectile function was evaluated by 
measuring intracavernosal pressure in response to electrical field stimulation of the cavernosal 
nerve. Coronary artery endothelial function (CAEF) was evaluated ex vivo with cumulative doses 
of (ACh) applied to pre-constricted segments of the left anterior descending coronary artery. 
Erectile function was significantly attenuated following 8-weeks (P < 0.05) and 12-weeks (P < 
0.05) of the WD, whereas CAEF was significantly attenuated following 12-weeks of the WD (P 
< 0.01). Larger groups of rats were then fed the CD or WD for 12 weeks, and erectile function 
and CAEF were evaluated following intracavernosal injection or vessel incubation with 
apocynin, an NADPH oxidase inhibitor. Apocynin improved erectile function (P < 0.01) and 
CAEF (P < 0.05) in WD, and had no effect on CD rats. Sedentary, young adults were recruited 
across a body mass index (BMI) range of 18-40, and split into BMI tertiles. Microdialysis probes 
were inserted into the vastus lateralis, and in vivo reactive oxygen species (ROS) production was 
measured, and microvascular endothelial function was assessed via local ACh-stimulated blood 
flow.  ROS production (P < 0.05) was elevated and ACh-stimulated blood flow (P < 0.05) was 
attenuated in the highest BMI tertile compared to both other tertiles. Apocynin had a greater 
effect of attenuating ROS production (P < 0.05) and augmenting ACh-stimulated blood flow (P < 
0.05) in the highest compared to lowest BMI tertile. These studies suggest that NADPH oxidase 
contributes to obesity associated erectile dysfunction, peripheral endothelial dysfunction, and 
coronary artery disease development.  
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CHAPTER 1: INTRODUCTION 
 Obesity is a major health care concern in the United States, the prevalence of which has 
risen from 19% in 1997 to over 33% in 2008 (1). Furthermore, obesity is no longer strictly an 
American problem. Obesity rates have drastically risen in Western and Central Europe since the 
1980’s, and continue to rise in much of the developing world (2). Cardiovascular complications 
involving both microvascular and macrovascular tissues are the major cause of morbidity and 
mortality in obese patients (3). Obesity has shown to be an independent risk factor for coronary 
(4) and systemic (5) endothelial dysfunction, which are detectable before the onset of diabetes 
(6). Endothelial dysfunction is a term that encompasses various functional alterations in the 
vascular endothelium, such as impaired vasodilation, angiogenesis, barrier dysfunction, and 
inflammatory activation. All of these functional alterations often occur early in the course of 
vascular diseases associated with obesity and the metabolic syndrome such as atherosclerosis, 
hypertension, and diabetes (7, 8). A dysfunctional endothelium induces vasoconstriction, platelet 
aggregation, monocyte adhesion, thrombosis, and inflammation, all of which promote the 
formation of vascular lesions (9, 10). Impaired vasodilator responses at the level of the resistance 
vessels leading to the nutritive capillary beds develop progressively, together with an increase in 
adiposity (11-13). Thus, obesity may promote the development of endothelial dysfunction 
throughout the vascular tree. With very limited access to the human coronary vasculature, 
understanding developmental patterns of endothelial dysfunction in various vascular beds in 
response to obesity is potentially powerful with respect to CVD risk assessment and prevention. 
Furthermore, development of innovative, minimally invasive approaches to studying the 
peripheral vasculature will aid in understanding of mechanistic aspects of vascular disease 
development.
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Epidemiological studies indicate that obesity is a significant, independent risk factor for 
erectile dysfunction (ED) (14-16). Reduction in erectile function may be an early indication of 
cardiovascular risk as patients with ED are twice as likely to develop major adverse cardiac 
events compared to those without ED (17). Recognition of reduced erectile function may be an 
important indicator of future adverse cardiac events, as clinical trial data suggests that the 
presence of ED in otherwise healthy men may be associated with early, subclinical signs of 
coronary artery disease (CAD) that may not be detectable during stress testing (18-21). The time 
interval between the onset of ED symptoms and the occurrence of CAD symptoms is estimated 
at 2-3 years, and an estimated 3-5 years between onset of ED and a cardiovascular event 
(myocardial infarction or stroke) (22-24). Additionally, multiple regression analysis indicates 
that ED is the most efficient predictor of silent CAD in apparently uncomplicated type 2 diabetic 
patients among a host of traditional cardiovascular disease (CVD) risk factors (25). However, 
differential development patterns of ED and CAD have not previously been investigated in a 
rodent model.  
 Impaired endothelial function appears to be due, at least in part to excess oxidative stress 
(8, 26), as oxidative stress in the vascular wall is a prominent feature of vascular disease (27, 28). 
Oxidative stress is increased in obesity (6, 12, 29, 30), thus excessive oxidative stress may link 
obesity to vascular disease and may be a prominent contributor to the reduction in endothelial 
function observed in obesity. NADPH oxidase, in particular, is considered a prominent source of 
vascular derived reactive oxygen species (ROS), the expression of which has shown to be 
elevated in arteries of human diabetes and CAD patients (31, 32). Nitric oxide (NO) is a major 
mediator of penile erection (33) and regulator of blood flow and vasomotor tone in the coronary 
and peripheral circulation (34, 35). A critical requirement for normal NO synthase (NOS) 
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functioning is an adequate presence of the essential co-factor tetrahydrobiopterin (BH4) (36). A 
potential consequence of increased NADPH oxidase activity is oxidation of BH4, an essential 
cofactor of endothelial nitric oxide synthase (eNOS) (36). Oxidation of BH4 induces cellular BH4 
depletion, which destabilizes NOS and induces a state of “uncoupling”, where NOS produces a 
proportionally higher amount of superoxide and lower amount of NO (36). Administration of 
sepiapterin stimulates intracellular BH4 production (37, 38), providing a potential 
pharmacological means of reversing NOS uncoupling.  
 In rodent models, diets rich in saturated fat and sucrose have been used to induce aortic 
endothelial dysfunction (39, 40). In human populations, the Western diet has been associated 
with inflammation and presence of vascular adhesion molecules (41), while adipose tissue 
concentrations of linoleic acid have been positively associated with CAD development (42). 
Over the past two decades there has been motivation to replace some of the saturated fat in the 
American diet with polyunsaturated fatty acids (PUFA), resulting in mass consumption of 
vegetable oils that are rich in linoleic acid (43). Additionally, it is estimated that the percentage 
of daily energy intake derived from added sugars is in excess of 25% in the upper sugar 
consumption tertile of Americans (44, 45).  
 Exercise training is known to protect against cardiovascular disease (46). Four weeks of 
aerobic exercise training prior to bypass surgery in human CAD patients has been shown to 
depress internal mammary artery ROS generation, NADPH oxidase activity, gp91
phox
 protein 
expression, as well as augment the acetylcholine-stimulated vasodilatory response. Aerobic 
interval training in particular has shown to produce several positive health benefits in patients 
with heart failure or the metabolic syndrome, including increases in aerobic capacity, flow-
4 
 
mediated dilation, insulin sensitivity, as well as decreases in fatty acid synthase (47, 48). In rats 
bred for low running capacity, aerobic interval training has had a greater effect on improving 
VO2max, insulin signaling, and aortic endothelial function than continuous moderate exercise 
training (49). Thus, aerobic interval training may be a particularly beneficial intervention at 
reversing or preventing endothelial dysfunction that may act through depression of NADPH 
oxidase activity. 
The purpose of the studies of this dissertation was to investigate the impact of NADPH 
oxidase on obesity associated endothelial dysfunction in the peripheral vascular bed, coronary 
artery, and penile tissue via assessment of erectile function. Additionally, we sought to 
investigate the efficacy of an aerobic interval training program on prevention or reversal of these 
obesity associated vascular dysfunctions. As clinical studies suggest that erectile dysfunction 
manifests prior to detectable signs of coronary artery disease (18-21), we initially sought to 
investigate the time course of development of erectile dysfunction relative to the development of 
coronary artery endothelial dysfunction in rats fed a Western diet that is high in saturated fat and 
omega-6 (n-6) PUFA derived from linoleic acid, as well as simple sugars. We further sought to 
investigate NADPH oxidase as common mechanisms leading to Western diet associated 
impairment of erectile function and coronary artery endothelial function at a time point where 
both erectile function and coronary artery endothelial function are impaired. Additionally, we 
sought to develop a novel, minimally invasive technique by which to measure in vivo ROS 
production and microvascular endothelial function in peripheral vascular beds of humans, and to 
investigate the impact of NADPH oxidase on in vivo ROS production and microvascular 
endothelial dysfunction associated with human obesity. We further sought to investigate the 
impact of an 8-week aerobic interval training intervention on in vivo ROS production and 
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microvascular endothelial function. These studies were designed to address the following 
specific aims: 
Aim 1) To determine if development of erectile dysfunction precedes coronary artery 
endothelial dysfunction in response to a Western diet. 
Aim 2) To determine if augmented NADPH oxidase activity contribute to diet-induced 
erectile dysfunction and/or coronary artery endothelial dysfunction. 
Aim 3) To determine if NADPH oxidase derived ROS contribute to peripheral 
endothelial dysfunction in obese individuals. 
 
 
CHAPTER 2: REVIEW OF LITERATURE 
Reactive Oxygen Species 
Oxidative stress is traditionally used to describe situations in which the generation of 
oxidants overwhelms antioxidant defense systems, resulting in oxidative damage to host tissue 
macromolecules. Oxidative stress may result from an increased production of oxidants and/or a 
decrease in antioxidant defense mechanisms (50). The production of oxidants refers to the 
production of ROS, which are redox derivatives of oxygen. The parent molecule of the ROS 
cascade is the superoxide anion (O2
-
) that is formed by the addition of an electron to O2. O2
-
 is a 
very short lived, highly reactive molecule that can be dismutated spontaneously into the 
hydroperoxyl radical (HOO
-
), hydrogen peroxide (H2O2), or peroxynitrite (ONOO
-
), or 
enzymatically by superoxide dismutase (SOD) into H2O2 (50). ROS act as intracellular signaling 
molecules that modulate many biochemical processes (51), however, in the state of excessive 
ROS production the signaling process acts to decrease NO bioavailability and cause damage to 
lipids, proteins, and DNA. As a consequence, apoptosis and increased cellular permeability may 
occur, which lead to endothelial dysfunction, inflammation, and vascular remodeling which all 
contribute to cardiovascular disease pathologies (28).  
 Within the vasculature, NADPH oxidase, eNOS, and xanthine oxidase (XO) are 
considered the major sources of ROS (8, 28, 52). NADPH oxidase in particular has been shown 
to be the predominant producer of ROS within vascular tissue (27, 53). NADPH oxidase is a 
protein consisting of multiple subunits located in the cytosol (p40
phox
, p47
phox
, p67
phox
, the small 
GTPase Rac) and the cellular membrane (p22
phox
, gp91
phox
). The membrane bound catalytic 
subunits gp91
phox
 and p22
phox
 contain the complete machinery for O2
-
 production and produce 
low levels of O2
-
 in the absence of stimulation by the cytosolic subunits (28). Complete
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activation of the catalytic subunits likely involves the translocation of p47
phox
 and p67
phox
 from 
the cytosol and binding to the membrane complex, a process stimulated by the PKC-dependent 
serine phosphorylation of p47
phox
 (54, 55). Upon activation, the membrane bound subunits utilize 
intracellular NADH or NADPH and transfer electrons across the membrane which reduce 
extracellular O2 to O2
-
 (27, 55). NADPH oxidase activity can be inhibited pharmacologically by 
apocynin, a catechol from the herb Picroria kurroa which impedes the assembly of p47
phox
 and 
p67
phox
 within the membrane complex (56), or by diphenylene iodonium (DPI) which disrupts 
electron flow through flavoproteins including NADPH oxidase and NOS.  
 Xanthine oxidases catalyze the oxidation of hypoxanthine to xanthine and xanthine to 
uric acid. Reoxidation of a fully reduced xanthine oxidase involves the transfer of six electrons to 
O2, yielding two molecules of H2O2 and two molecules of O2
-
 (28). Xanthine oxidases are widely 
distributed throughout the body, however there is a circulating form of XO that can bind to 
glycosaminoglycans on the surface of endothelial cells and may acquire increased stability and 
oxidant-producing capacity upon binding (57). Xanthine oxidase does not appear to be as 
significant of a source of vascular ROS as NADPH oxidase in conditions of increased oxidative 
stress. XO is increased in the coronary arteries of patients with CAD, but treatment with 
oxypurinol, a XO inhibitor does not inhibit vascular O2
-
 production nearly to the extent that DPI 
and apocynin do (32). Treatment of cultured endothelial cells with lysophosphatidylcholine 
induces increased ROS generation which can be blunted by DPI but not allopurinol, a XO 
inhibitor (58). DPI also significantly attenuates ROS generation in endothelial cells subjected to 
high-glucose conditions, where oxypurinol does not (59). Similarly, excessive ROS generation in 
aortic segments from spontaneously hypertensive rats can be attenuated by DPI and apocynin, 
but not oxypurinol (60).  
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Nitric Oxide 
Nitric oxide (NO) is the primary vasodilator produced by the endothelium which 
regulates blood flow and vasomotor tone in the coronary and peripheral circulation (34, 35). 
Inhibition of NO production reduces whole-limb blood flow and nutritive blood flow at the 
microvascular level (35, 61). NO is a lipid soluble gas that rapidly diffuses into the vascular 
smooth muscle where it binds to guanylate cyclase, resulting in an increase of guanosine 3’,5’-
cyclic monophosphate (cGMP) production which induces smooth muscle relaxation and vascular 
dilation (62, 63). NO is produced within the vasculature by endothelial nitric oxide synthase 
(eNOS) which converts L-arginine and O2 to NO and L-citrulline.  
eNOS is a homodimeric protein robustly expressed in endothelial cells that requires 
several redox-active cofactors, including nicotinamide adenine dinucleotide phosphate 
(NADPH), flavin adenine dinucleotide (FAD), flavin mononucleotide (FMN), calmodulin, and 
tetrahydrobiopterin (BH4) (64, 65). eNOS is primarily membrane bound and associated with 
golgi membranes and plasmalemmal caveolae (66, 67). The binding of eNOS and caveolin 
inhibits the enzymatic activity, which is reversed upon binding of Ca
2+
/calmodulin (68).  
 eNOS is activated by an increase of intracellular Ca
2+
, which can be induced by agonists 
such as thrombin, bradykinin, acetylcholine, VEGF, and insulin, or by an increase in blood flow 
via the subsequent increase in vascular shear stress (69-72). Activation of eNOS is also regulated 
by phosphorylation status, where phosphorylation at Ser
1177
, Ser
633
, and Ser
614
 are stimulatory, 
and phosphorylation at Thr
495
 and Ser
116
 are inhibitory (73). Ser
1177
 phosphorylation activates 
eNOS catalytic activity via inhibition of calmodulin dissociation from eNOS and enhancement of 
the internal rate of eNOS electron transfer (70, 74). Phosphorylation of Ser
1177
 is catalyzed by 
Akt, cyclic AMP-dependent protein kinase (PKA), cyclic GMP-dependent protein kinase (PKG),  
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AMP-activated protein kinase (AMPK), and Ca
2+
/calmodulin-dependent protein kinase II (75). 
Thr
495
 phosphorylation interferes with the binding of calmodulin by eNOS, thus 
dephosphorylation of Thr
495
 enhances the interaction of eNOS and calmodulin (76). Protein 
kinase C (PKC) is most likely the kinase responsible for phosphorylation of Thr
495
, while serine-
threonine protein phosphatase I (PP1) is the most likely phosphatase that dephosphorylates 
Thr
495
 (65). eNOS activity is further enhanced by its association with heat shock protein 90 
(Hsp90). Hsp90 undergoes tyrosine phosphorylation in response to various eNOS agonists, 
allowing it to associate with eNOS (77, 78). Hsp90 binding stimulates eNOS activity by 
enhancing the affinity of eNOS for binding calmodulin and by enhancing the interaction of 
eNOS with Akt which increases the rate of Akt-dependent Ser
1177
 phosphorylation (79, 80). 
Agonist-stimulated eNOS activation is thus induced by simultaneous changes in Ser
1177
 and 
Thr
495
 phosphorylation and Hsp90 binding, resulting in changes in the accessibility of the 
calmodulin-binding domain of eNOS to calmodulin, which displaces caveolin from eNOS to 
release the tonic eNOS inhibition (64, 65).  
 NO bioactivity is used as a practical surrogate for endothelial function, thus a reduced 
ability of the endothelium to produce NO is commonly the defining characteristic of endothelial 
dysfunction. Despite endothelial dysfunction increasing with adiposity and metabolic syndrome 
associated diseases (7, 8, 81), the role of the eNOS protein in this progression is unclear. eNOS 
mRNA has been shown to be increased in streptozotocin-induced diabetic rat glomerulus, despite 
a decrease in glomerular NO production (82). Similarly, eNOS protein expression has shown to 
be increased in cerebral microvessels of diabetic obese Zucker rats despite the cerebral arterioles 
of these rats exhibiting an impaired vasorelaxation response to acetylcholine and ADP (83). 
Additionally, eNOS protein expression increases in cultured mouse microvessel endothelial cells 
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(84, 85) and human aortic endothelial cells (86) when exposed to high glucose conditions despite 
a decrease in NO production. eNOS protein expression has also been shown to be increased in 
the aortic wall of LDLR
-/-
 mice fed an atherogenic diet compared to a group fed a normal diet 
(87). Fulton et al (88) observed no change in eNOS protein expression in heart, skeletal muscle, 
aorta, or cardiac eNOS mRNA levels in insulin resistant obese Zucker rats compared to lean 
Zucker rats, in addition to no differences in cardiac eNOS Thr
494
 [Thr
495
(hum)], or Ser
632
 
[Ser
633
(hum)] phosphorylation or eNOS-Hsp90 protein-protein interaction. An increase in Ser
1176
 
[Ser
1177
(hum)] phosphorylation was observed in OZR despite an impaired vasodilatory response 
to acetylcholine and reduced serum NO2
-
 (88). However, both eNOS protein content and activity 
has been shown to be reduced in skeletal muscle homogenates of overweight humans relative to 
lean counterparts (89). One possible explanation for the observation of increased eNOS 
expression coinciding with reduced NO production or vasodilatory response to acetylcholine is 
the phenomena of eNOS uncoupling, with subsequent compensatory upregulation of eNOS 
mRNA and protein content.  
ENOS Uncoupling 
Under normal conditions, eNOS is a homodimeric oxidoreductase, where the reductase 
domain generates electron flow from NADPH through the flavins FAD and FMN that are 
transferred to the oxidase domain of the other monomer where L-arginine oxidation occurs at the 
heme group in the active site (36). A critical requirement for normal eNOS functioning is an 
adequate presence of the cofactor tetrahydrobiopterin (BH4). BH4 binds close to the heme active 
site at the interface between the two monomers, interacting with residues from both (90). 
Maintenance and stabilization of eNOS dimers is dependent on BH4, which also plays a role in 
the oxidation of L-arginine and the subsequent generation of NO. When BH4 is limited or absent, 
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eNOS dimerization is destabilized, leading to a reduction in the relative proportion of eNOS 
dimers to monomers present in the cell. Additionally, eNOS catalytic activity becomes 
“uncoupled”, where the stoichiometric coupling between the reductase domain and L-arginine 
oxidation at the active site is lost. However, electron transfer from NADPH through the flavins 
to O2 is not inhibited, but results in the formation of O2
-
 rather than NO (36).  
 Uncoupling of eNOS has been demonstrated by Zou et al (91) who showed that 
recombinant eNOS lacking L-arginine or BH4 does not form L-citrulline, but does exhibit 
Ca
2+
/calmodulin-dependent NADPH oxidase activity. O2
-
 production is markedly increased in 
apoE
-/-
 mouse aortas, but can be attenuated by removal of the endothelium or by sepiapterin (a 
BH4 precursor) exposure (92). Sepiapterin exposure to these aortic rings also improves the 
vascular relaxation response to acetylcholine and the calcium ionophore A23187, demonstrating 
the endothelial dependence of sufficient BH4 levels (92). Furthermore, the eNOS:BH4 ratio 
correlates with L-NAME inhibitable O2
-
 production in cells with varying BH4 concentrations, 
showing a BH4 concentration dependence for eNOS “coupling” (93). BH4 concentrations may be 
modulated by synthesis or metabolism. Guanosine triphosphate cyclohydrolase-1 (GTPCH-1) 
catalyzes the conversion of GTP to dihydroneopterin, where BH4 is synthesized by further steps 
catalyzed by 6-pyruvoyltetrahydropterin synthase and sepiapterin reductase, though GTPCH-1 
appears to be the rate limiting enzyme in BH4 synthesis (94, 95). BH4 concentration may also be 
lowered by partial oxidation to dihydrobiopterin (BH2), which goes through a BH3
+
 intermediate 
(96). BH4 may then be regenerated from BH2 by dihydrofolate reductase (DHFR) (95). Indeed, 
knockdown of GTPCH-1 and DHFR attenuates VEGF-induced eNOS activity and NO 
production, which can be recovered by BH4 supplementation (97). Supplementation of 
endothelial cells with BH2 also attenuates VEGF-induced NO production and increases ROS 
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production, which can be increasingly reversed by increasing concentrations of BH4 
supplementation (97). Increasing BH2 levels cause an inhibition of dephosphorylation of eNOS 
at Ser
116
, which can also be recovered by supplementation with BH4 (97). These findings indicate 
that the activity state of eNOS is not just reliant on intracellular BH4 concentrations, but may be 
influenced by the BH4:BH2 ratio which is dependent upon the cellular redox state. The 
vasoprotective effects of ascorbic acid may potentially be mediated through maintenance of 
intracellular BH4 concentrations and stabilization of the eNOS dimer. Supplementation of 
cultured endothelial cells with ascorbic acid has shown to preserve eNOS acitivity and NO 
production by recycling the BH3
+
 radical back to BH4 (98). Chronic oral supplementation of 
apoE
-/-
 mice with ascorbic acid increases the aortic BH4/BH2 ratio, restores eNOS activity, and 
augments the vasodilatory response to acetylcholine (99).  
 Depletion of intracellular BH4 levels in various disease states appears to be dependent 
upon enhanced generation of ONOO
-
. Exposure of cultured endothelial cells to O2
-
 modestly 
degrades BH4, but exposure to even lower concentrations of ONOO
-
 degrades BH4 to a much 
greater extent (92). Even in the absence of overt disease, exposure of C57Blk/6 rat aortic rings to 
ONOO
-
 increases O2
-
 production, which can be attenuated by L-NAME, sepiapterin, or 
endothelial denudation (92). Similarly, exposure of BAECs to ONOO
-
 results in reduced NO 
production, as well as increased O2
-
 production which is inhibitable by L-NAME and BH4 
administration (96). Exposure of apoE
-/-
 mouse aortic rings to uric acid, a ONOO
-
 scavenger, 
attenuated O2
-
 production and enhanced vascular relaxation to acetylcholine and A23187 (92). 
Additionally, NO production is preserved in cultured endothelial cells exposed to ONOO
-
 in the 
presence of uric acid, but not SOD, supporting the hypothesis that reduced NO production is the 
result of eNOS uncoupling rather than inactivation by O2
-
 (96). Furthermore, recombinant eNOS 
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subjected to increasing concentrations of ONOO
-
 increases eNOS monomers and decreases 
eNOS dimers, which coincides with decreased eNOS activity, decreased L-citrulline formation, 
and increased NADPH oxidation (91). ONOO
-
 exerts its action upon eNOS by oxidizing the 
zinc-thiolate cluster, which causes the release of zinc and consequently cleaves the dimers into 
monomers under reducing conditions (91).  
 ONOO
-
 is formed by the combination of O2
-
 and NO. NADPH oxidase appears to be the 
predominant enzyme that contributes O2
-
 to enhanced ONOO
-
 production within the vasculature. 
Vascular O2
-
 production is enhanced in deoxycorticosterone acetate-salt (DOCA-salt) induced 
hypertensive rats (100). The enhanced O2
-
 production appears to be mediated through eNOS 
uncoupling as O2
-
 production is attenuated by L-NAME or removal of the endothelium, in 
addition to eNOS
-/-
 mice exhibiting no increase in O2
-
 production when treated with DOCA-salt 
(100). BH4 content is also attenuated in DOCA-salt hypertension, however both BH4 levels and 
O2
-
 production are normal in DOCA-salt treated p47
phox-/-
 mice, indicating that eNOS is not 
uncoupled by DOCA-salt hypertension in the absence of fully functioning NADPH oxidase 
(100). Thus, NADPH oxidase may be the O2
-
 source that creates ONOO
-
. Similarly, angiotensin 
II infusion into rats induces hypertension, along with an increase in aortic eNOS mRNA and 
protein expression and a decrease in NO production (101). The enhanced O2
-
 production induced 
by angiotensin II is attenuated by treatment with the PKC inhibitor chelerythrine, indicating that 
PKC somehow contributes to vascular O2
-
 production (101). These pathways have been further 
investigated by Xu et al (102), who found that treatment of HUVECs with hypochlorous acid 
(HOCl) increased O2
-
 production and dose dependently decreased the eNOS dimer:monomer 
ratio. HOCl treatment also increased phosphorylation of PKC-ζ and translocation of p67phox and 
p47
phox
 from the cytosol to the plasma membrane, all of which is abolished by PKC-ζ inhibition 
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(102). HOCl enhanced O2
-
 production was suppressed by apocynin and abolished in p67
-/-
 mice, 
while eNOS dimer dissociation was blocked in p67
-/-
 mice and in mouse aorta by treatment with 
uric acid (102). Similar results have been observed by Guzik et al (31, 32) in diseased human 
arteries. Internal mammary arteries of diabetic patients and coronary arteries of CAD patients 
exhibit increased endothelial O2
-
 production and an upregulation of p22
phox
, p47
phox
, and p67
phox
 
coinciding with increased NADPH oxidase activity (31, 32). The elevation in O2
-
 production by 
diabetic vessels is inhibited by sepiapterin and chelerythrine (31). Taken together, these results 
indicate that upregulation of vascular O2
-
 production by NADPH oxidase may be mediated by 
PKC, and may increase ONOO
-
 formation in vascular disease states, and in turn lead to eNOS 
uncoupling through oxidation of BH4, which reduces NO production and further increases 
endothelial O2
-
 production.  
Exercise Training 
Regular exercise training is associated with increased vasodilator capacity as several 
longitudinal studies provide convincing evidence for the antiatherogenic effect of regular 
physical activity (81). Exercise has also been shown to be an effective method in which to 
improve endothelial dysfunction in conditions associated with obesity such as 
hypercholesterolemia, hypertension, Type 2 diabetes, CAD, and heart failure (81). In addition to 
simple prevention of atherogenesis, exercise training can improve vascular function in healthy 
individuals. Both continuous moderate intensity exercise and high-intensity interval training 
improve vasodilator capacity in popliteal arteries of healthy human subjects (103). Aortic 
relaxation to acetylcholine is improved 24 hours after a single bout of high-intensity interval 
training in healthy rats, and improves to a greater degree following six weeks of training (104). 
Chronic high-intensity interval training has also shown to improve VO2max and aortic relaxation 
15 
 
to acetylcholine more than continuous moderate intensity exercise in rats bred for a low running 
capacity, which corresponds to a 2-fold increase in aortic eNOS protein expression (49). Chronic 
high-intensity interval training also has shown to improve relaxation to acetylcholine in white 
gastrocnemius arterioles of healthy rats, alongside increases in eNOS protein expression in the 
aorta, iliac artery, femoral artery and various gastrocnemius arterial branches (105). Continuous 
moderate intensity exercise has shown to increase eNOS protein expression in human internal 
mammary arteries (106), in rat aorta (107, 108), left ventricle (109) and aged rat cavernosum 
(110), but did not change eNOS protein expression in rat soleus muscle, however soleus eNOS 
activity, Ser
1179
 phosphorylation, and eNOS-Hsp90 association were all increased (111).  
 Improvements in vasodilator capacity resulting from aerobic exercise training may at 
least in part be due to reductions in oxidative stress. Four weeks of aerobic exercise prior to 
bypass surgery in patients with CAD has shown to improve internal mammary artery relaxation 
to acetylcholine and increase eNOS mRNA, protein expression, Ser
1177
-phosphorylation/eNOS 
protein ratio, and Akt-phosphorylation (106). The same training stimulus has been shown to 
decrease internal mammary artery ROS generation, NADPH oxidase activity, and gp91
phox
 
mRNA and protein expression (112). Chronic endurance exercise has also shown to reduce O2
-
 
production and NADPH oxidase activity in apoE
-/-
 mice (108), and reduce p67
phox
 expression in 
miniature swine aortic endothelium (113) and the carotid arteries of old mice (107), while 
apocynin only improved vasodilation to acetylcholine in the old sedentary mice which had 
reduced eNOS expression and Ser
1177
-phosphorylation. Similarly, exercise reduced aortic O2
-
 
production, NADPH oxidase activity, p47
phox
 and p67
phox
 expression in healthy mice, which 
corresponded with an increase in eNOS mRNA and protein expression (108). Chronic exercise 
training has also shown to attenuate NADPH oxidase activity and markedly augment eNOS 
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dimers in the left-ventricle of diabetic Goto-Kakizaki rats (109), while BH4 supplementation has 
shown to augment flow-mediated dilation in old sedentary individuals, but not in old exercise 
trained individuals (114), suggesting that chronic exercise training may prevent eNOS 
uncoupling. Some of the vasoprotective effects of exercise may be mediated through the increase 
in vascular shear stress. Duerrschmidt et al (115) found that short term application of shear stress 
to HUVECs increased O2
-
 formation, while long-term shear stress decreased O2
-
 formation, 
gp91
phox
 and p47
phox
 mRNA and protein expression along-side an increase in NO formation and 
eNOS protein expression. The effects of shear stress on oxidative stress appear to be due to 
enhanced NO formation as application of an NO donor mimics the effects of long term shear 
stress resulting in decreases in O2
-
 formation, gp91
phox
, and p47
phox
, while the downregulation of 
O2
-
 formation, gp91
phox
, and p47
phox
 by long-term shear stress can be blocked by co-application 
of L-NAME (115). Thus, exercise may regulate NADPH oxidase derived O2
-
 production by the 
endothelium through a shear-stress induced increase in NO bioavailability. This mechanism may 
contribute to the regulation of endothelial NO/O2
-
 balance and the antiathersclerotic and 
vasoprotective potential of shear-stress and aerobic exercise. These findings suggest that aerobic 
exercise may downregulate NADPH oxidase activity in endothelial dysfunction states through an 
increase in NO production mediated by vascular shear stress.   
 
Erectile Function 
A number of epidemiological studies indicate that obesity is a significant, independent 
risk factor for erectile dysfunction (ED) (14, 16, 116). In addition, abdominal obesity and a 
sedentary lifestyle each result in an approximately 50% greater likelihood of having ED, 
regardless of BMI (117). Similar to many cardiovascular risk factors, ED is more highly 
associated with Western-style dietary intake than Mediterranean-style dietary intake (41, 118). 
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Reduction in erectile function may be an early indication of cardiovascular risk, as patients with 
ED are twice as likely to develop major adverse cardiac events compared to those without ED 
(17). Recognition of reduced erectile function may be an important indicator of future adverse 
cardiac events, as clinical trial data suggests that the presence of ED in otherwise healthy men 
may be associated with early (subclinical) signs of CAD that may not be detectable during stress 
testing (18-21). The time interval between the onset of ED symptoms and the occurrence of CAD 
symptoms is estimated at 2-3 years, and an estimated 3-5 years between onset of ED and a 
cardiovascular event (myocardial infarction or stroke) (22-24). It is estimated that men younger 
than 60 with ED have a 2.3 higher probability of having CAD compared to those that do not 
have CAD (119). Furthermore, men with ED generally exhibit more severe CAD than those 
without ED, and the severity of ED may also correlate with the severity of CAD (24, 120-122). 
Lifestyle interventions such as diet and exercise are known to augment coronary endothelial 
function in CAD patients (32, 112), thus it is reasonable that such interventions may positively 
impact erectile function in ED patients. Indeed, Esposito et al. demonstrated that obese men 
given diet and activity advice both lost weight and improved self-reported erectile capacity, 
while improvements in erectile function correlated with improvements in metabolic profile 
(123). Moderate intensity treadmill running has also shown to preserve cavernosal strip 
relaxation to ACh (124) and NMDA induced erectile function in STZ-diabetic rats (125). The 
association between risk factors for the metabolic syndrome, ED and CVD is strong, and given 
that the prevalence of ED is projected to double by 2025 (from 1995) (126) , it is imperative that 
the common underlying mechanisms be identified and ED be recognized as an early and 
preventable risk factor for CAD. Currently it is likely that ED prevalence is higher than reported 
and corresponds more closely to the current prevalence of obesity. In a study where men with 
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obesity or at least one component of the metabolic syndrome were asked if they had erectile 
dysfunction, follow-up administration of the Erectile Function domain of the International Index 
of Erectile Function (IIEF) questionnaire revealed that of men responding “yes” 96% had ED, of 
men responding “unsure” 90% had ED, and of men responding “no” 36% had ED (127). This 
lack of recognition of ED symptoms highlights an important need for increased screening for ED 
to potentially unmask common underlying CAD symptoms.  
 Electrical field stimulation (EFS) of the major pelvic ganglion or cavernosal nerve in rats 
provides an in vivo method in which to evaluate erectile function. This method provides a means 
to obtain information on the quality of erections assessed as an increase in intracavernosal 
pressure (ICP) relative to mean arterial pressure (MAP), a method which has provided a 
significant amount of our knowledge of erectile function over the past two decades (128). 
Reduced ICP to FES has been observed in several rodent models of the metabolic syndrome, 
such as diabetic models induced by streptozotocin (129, 130) and alloxan (131), obese-diabetic 
Zucker rats (132), Goto-Kakizaki diabetic rats (133), angiotensin II supplemented (134), DOCA-
salt (135), and spontaneously hypertensive rats (135, 136), as well as ApoE
-/-
 mice fed a 
hypercholesterolemic diet (137) and LDLR
-/-
 mice fed a western diet (138). Similar to 
endothelial dysfunction elsewhere, ROS is implicated in the pathogenesis of erectile dysfunction 
(139, 140). Increased oxidative stress has been observed in cavernosal tissue of several models, 
including streptozotocin-induced diabetes (129, 130, 141, 142), angiotensin II supplemented 
(134) and spontaneously hypertensive rats (143), LDLR
-/-
 mice fed a western diet (138), high-fat 
diet fed pigs (144), and cholesterol fed rabbits (145). Furthermore, chronic anti-oxidant treatment 
with α-lipoic acid partially corrected cavernosal ACh-stimulated relaxation (130), while 
supplementation of the anti-oxidant AC3056 (141) and SOD-transfection (129) improve voltage-
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dependent erectile response in STZ-diabetic rats. NADPH-oxidase induced eNOS uncoupling 
presents an attractive hypothesis for the source of elevated ROS/reduction in erectile function. 
Exposure of cavernosal strips to apocynin improves both relaxation to an ACh analog and 
attenuates ROS production from hypercholesterolemic rabbits, while allopurinol and rotenone 
were ineffective (145). Similarly, drinking-water supplementation of apocynin blunts the 
elevated cavernosal p47
phox
 content and oxidative stress in hypertensive (134) and 
hypercholesterolemic (138) models and restores the eNOS dimer/monomer ratio (138). 
Additionally, oral supplementation of BH4 to men with mild ED improved erectile response to 
visual stimulation (146), while four days of sepiapterin injection improves voltage-dependent 
erectile response in aged rats (147). Furthermore, there is reason to believe that this mechanism 
of attenuated erectile function can be prevented by exercise training. Treadmill running of high-
fat diet fed pigs preserved cavernosal cGMP and eNOS dimer/monomer ratio compared to their 
sedentary high-fat diet counterparts (144).  
 Consistent with the hypothesis that erectile dysfunction is an early indicator of future 
CAD, it is likely that a reduction in erectile dysfunction occurs prior to the onset of coronary 
endothelial dysfunction (132, 148, 149). In 17-18 week old lean (LZR) and obese Zucker rats 
(OZR), there is a 4-fold increase in the media:lumen ratio in the penile arteries of OZR compared 
to LZR, where no difference was observed in the coronary arteries (149). This finding indicates 
that atherosclerotic development occurs in the penile artery prior to the coronary artery, and 
reflects the state of endothelial function as the vasodilatory response to ACh in the OZR is 
attenuated in the penile artery but not the coronary artery (149). Oltman et al. (148) found similar 
results as there was no difference in the coronary vasodilatory response to ACh between LZR 
and OZR at 16-24 weeks of age, however this response was attenuated in OZR at 28-36 weeks of 
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age. It is also likely that the reduction in penile artery endothelial dysfunction corresponds to 
erectile dysfunction as Wingard et al. (132) observed a reduction in ICP/MAP in OZR at 16-20 
weeks. These findings in Zucker rats may translate to other models of obesity. Ten weeks of 
high-fat diet attenuates ACh-stimulated vasodilatory response in the penile artery of Wistar rats 
(150), but not the coronary artery (151). However, there is likely a reduction in endothelial 
derived NO production and an alteration of the smooth muscle response to NO in the coronary 
arteries. The coronary ACh-stimuated vasodilatory response was significantly attenuated by L-
NAME treatment in lean but not obese animals (151). Additionally, the vasodilatory response to 
SNP is augmented in the obese animals (151). This obesity-related compensation by smooth 
muscle is likely present in the penile artery as ACh stimulates dilation of the penile artery in the 
presence of a NOS inhibitor in obese animals but not lean animals (150).   
Diet-Induced Obesity 
Several studies have demonstrated impaired endothelial function in diet-induced obese 
models in aortas of rats (39, 40, 152-154), mice (155), and coronary arteries of pigs (6, 156). 
Similar to obese Zucker rats, augmented sensitivity to NO has been demonstrated in diet-induced 
obese rat aortas (40, 153) and in a study where ACh-induced NO production was attenuated in 
coronary arteries despite no change in ACh-induced coronary flow in diet-induced obese dogs 
(157). There is indication that increased oxidative stress, increased NADPH oxidase activity and 
reduced eNOS activity contribute to endothelial dysfunction in this model. Attenuated eNOS 
content has been observed in aorta (39, 40, 152), heart (40), kidney (40), and gastrocnemius (39), 
along with attenuated aortic eNOS phosphorylation (154). In addition, eNOS content is 
attenuated in the cavernosum of diet-induced obese rats, which is restored with metformin 
treatment (158). Aortic gp91
phox
 (153), p47
phox
 (152), and cardiac p22
phox
 (159) expression are 
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elevated in diet-induced obesity and may be blunted by antioxidant treatment (152, 159). 
Elevated oxidative stress has been documented in this model by increased aortic nitrotyrosine 
(39, 152) and reversibility of endothelial dysfunction with SOD incubation (155). Additionally, 
endothelial dysfunction following diet-induced obesity appears to be reversible with the addition 
of exercise training and/or diet modification (154, 156).   
Summary 
Evidence has been provided in the above sections that oxidative stress in obesity may be 
a significant contributor to the reduction in nitric oxide bioavailability and ensuing vascular 
dysfunction often observed in conditions associated with obesity. Under this paradigm, vascular 
ROS is induced by an upregulation of NADPH oxidase activity which contributes to enhanced 
production of ONOO
-
, potentially leading to BH4 depletion by oxidation and dissociation of 
eNOS dimers into monomers. This situation results in a reduction in NO production and 
increased eNOS dependent O2
-
 production which further contribute to vascular oxidative stress 
and endothelial dysfunction. Current evidence suggests that endothelial dysfunction manifest as 
erectile dysfunction, peripheral endothelial dysfunction, or coronary endothelial dysfunction is 
prevalent in obesity and several models of the metabolic syndrome. It remains likely that these 
manifestations of endothelial dysfunction are linked through similar mechanisms, of which 
NADPH oxidase induced eNOS uncoupling is an attractive hypothesis. Chronic aerobic interval 
training, however, has the potential to ameliorate vascular oxidative stress and the ensuing 
endothelial dysfunction in obesity.
 
 
CHAPTER 3: METHODS 
Animal Studies 
Experimental Animals and Diets 
 Male Sprague-Dawley rats were purchased at 5, 9, or 13 weeks of age (Charles River 
Laboratories, Wilmington, MA) and housed in the Department of Comparative Medicine, in 
pairs when possible, in a temperature controlled room (22 ± 1°C) with a 12h:12h light dark 
cycle. For aim 1, rats were fed a Western diet (WD) (Teklad Diets 110365, Harlan Laboratories, 
Madison, WI) for the final 4 (n = 8), 8 (n = 8), or 12 (n = 5) weeks of life, or a control diet 
(Teklad Diets 110367, Harlan Laboratories, Madison, WI) for the final 8 (n = 5) weeks of life. 
For aim 2, rats were fed the Western diet (n = 11) or control diet (n = 12) while remaining 
sedentary for 12 weeks, or the Western diet (n = 11) or control diet (n = 8) through the duration 
of a 12 week exercise intervention. The Western diet was designed to be high in fat and sucrose, 
with an equal proportion of saturated fatty-acids (SFA) and PUFA, with a high proportion of n-6 
PUFA derived from linoleic acid. The control diet was designed to be a normal-fat, normal-
carbohydrate diet with equivalent levels of vitamins, minerals, and protein to the Western diet 
when considered on a basis of kcal density (Tables 1, 2). All rats were sacrificed at 19-20 weeks 
of age. All procedures were performed in accordance with the Guiding Principles in the Care and 
Use of Animals established by the National Institute of Health and approved by the Institutional 
Animal Care and Use Committee. 
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Table 1 Composition of the Western diet and Control diet. 
 
 
Western Diet Control Diet 
 
g/kg g/kg 
Casein 195 155 
L-Cystine 3 2.3 
Sucrose 340 150 
Corn Starch 62.46 445.19 
Maltodextrin 60 100 
Anhydrous Milkfat 120 26 
Soybean Oil 30 18 
Safflower Oil 80 6 
Cellulose 50 50 
Mineral Mix, AIN-93M-MX 44 35 
Vitamin Mix, AIN-76A 12.5 10 
Choline Bitartrate 3 2.5 
TBHQ 0.04 0.01 
 
 
  TBHQ, tert-butylhydroquinone.  
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Table 2 Macronutrient composition of the Western and control diets. 
 
 
Western Diet Control Diet 
kcal/g 4.68 3.67 
Fat, % by weight 23.2 5.2 
Carbohydrate, % by weight 47.6 66.3 
Protein, % by weight 17.3 13.7 
Fat, % of kcal 44.6 12.7 
Carbohydrate, % of kcal 40.7 72.4 
Protein, % of kcal 14.8 15 
SFA, % of total fatty acids 39 40 
MUFA, % of total fatty acids 24 26 
PUFA, % of total fatty acids 37 33 
C18:2 linoleic, % by weight 8.2 1.5 
C18:3 linolenic, % by weight 0.3 1.57 
n-6 to n-3 27 9.6 
Vitamin E, IU/kg 62 50 
 
 
SFA, saturated fatty acid; MUFA, mono-unsaturated fatty acid; PUFA, poly-unsaturated fatty 
acid 
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Exercise Intervention 
 Rats were acclimated to exercise by walking on a treadmill at 15 m/min at 0° inclination 
for 10 min/day for seven consecutive days prior to induction of the training/dietary intervention. 
The training protocol consisted of a maximal work capacity test at the beginning of each week, 
followed by aerobic interval training four days/week, for a total of five exercise days/week. The 
maximal work capacity test consisted of a 20-minute warm-up at ~50% VO2max, followed by 
incremental increases in speed of 2.0 m/min every two minutes until volitional fatigue, followed 
by at 10-minute cool-down at ~50% VO2max. The aerobic interval protocol consisted of a 10-
minute warm-up followed by eight intervals, each consisting of a four-minute high-intensity 
phase and three-minute low-intensity phase, followed by a four-minute cool-down as detailed in 
Table 3. Running intensity increased each week until a plateau was reached in maximal work 
capacity at week 9. Rats were encouraged to run primarily by compressed air, with every effort 
made to minimize the use of the electric shock grid at the back of the treadmill belt. This 
protocol was designed to approximate the intensities utilized in previous studies which 
demonstrate the beneficial impact of aerobic interval training on endothelial function and aerobic 
capacity relative to continuous moderate intensity exercise protocols (49, 160, 161). 
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Table 3 Treadmill aerobic interval training protocol. Treadmill speed was changed at the 
indicated time point. 
Week 1 2 3 4 5 6 7 8 9 10 11 12 
Incline 17° 17° 17° 17° 17° 17° 25° 25° 25° 25° 25° 25° 
Minute Speed (m/min) 
0 10 12 14 14 15 16 14 14 14 14 14 14 
10 19 20 21 22 23 24 21 22 22 22 22 22 
14 14 15 16 17 18 19 16 17 17 17 17 17 
17 19 20 21 22 23 24 21 22 22 22 22 22 
21 14 15 16 17 18 19 16 17 17 17 17 17 
24 19 20 21 22 23 24 21 22 22 22 22 22 
28 14 15 16 17 18 19 16 17 17 17 17 17 
31 19 20 21 22 23 24 21 22 22 22 22 22 
35 14 15 16 17 18 19 16 17 17 17 17 17 
38 19 20 21 22 23 24 21 22 22 22 22 22 
42 14 15 16 17 18 19 16 17 17 17 17 17 
45 19 20 21 22 23 24 21 22 22 22 22 22 
49 14 15 16 17 18 19 16 17 17 17 17 17 
52 19 20 21 22 23 24 21 22 22 22 22 22 
56 14 15 16 17 18 19 16 17 17 17 17 17 
59 19 20 21 22 23 24 21 22 22 22 22 22 
63 14 15 16 17 18 19 16 17 17 17 17 17 
66 10 12 13 14 15 16 13 14 14 14 14 14 
70 stop 
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Glucose, Insulin, and Lipid Profiles 
 All rats were fasted overnight prior to body composition studies. Approximately 0.3 ml 
of blood was drawn from the tail vein prior to anesthesia, from which fasting glucose 
concentration was measured from whole blood (Accu-Check, Roche, Basel, Switzerland). Blood 
was centrifuged for 20 min (4°C, 14,000 rpm), and plasma separated and frozen in a -80°C 
freezer until analyzed for insulin concentration with a rat/mouse insulin assay kit (Millipore, 
Billerica, MA). The homeostatic model of insulin resistance (HOMA-IR) was calculated from 
fasting glucose and insulin concentrations as HOMA-IR = [Insulin (mU/l) * Glucose 
(mmol/l)]/22.5 (162). Approximately 1.5 ml of blood was drawn through a splitter in the PE 
tubing upon placement and stabilization of the carotid cannula, at the onset of the erection 
assessment surgery, subsequently centrifuged and serum was separated and frozen until 
analyzed. Serum total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density 
lipoprotein cholesterol (LDL-C), and triglycerides were measured with a clinical mass analyzer 
(UniCel DxC 600, Beckman Coulter, Indianapolis, IN). 
HNE adducts 
 The relative amount of serum 4-hydroxynonenal (HNE)-adducts was determined by a 
modified ELISA approach. A standard curve of HNE-adducts was established by incubating 
HNE with pre-determined concentrations of bovine serum albumin (BSA). Following an 
overnight incubation at 37°C, HNE-BSA adducts were added to an Immunolon-coated 96-well 
assay plate (ThermoScientific, Rochester, NY, USA), along with diluted serum (1:40 in PBS). 
Samples were incubated overnight at 4°C, and subsequently washed with PBS+0.05% Tween-20 
and blocked for 2 hours with NB4025 (NOF Corp., Tokyo, Japan). Samples were then incubated 
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with anti-HNE antibody (1 µg/ml in PBS, Oxis Research, Beverly Hills, CA, USA), for 2 hours 
at 37°C. Samples were washed with PBS+0.05% Tween-20 and incubated with secondary 
antibody for 2 hours at 27°C (goat anti-mouse HRP, Bio-Rad, Hercules, CA, USA).  Following 
this incubation, samples were washed as before and incubated with tetramethylbenzene (TMBZ) 
for 20 minutes. Reactions were quenched with 1M sulfuric acid, and the absorbance of the 
samples at 450 nm was determined. 
Anthropometrics and Body Composition 
 Body weight was measured prior to surgery with a triple beam balance. Lean mass and 
fat mass were measured immediately prior to surgery by nuclear magnetic resonance-magnetic 
resonance imaging (NMR-MRI) (EchoMRI 700, Echo Medical Systems, Houston, TX). Body fat 
percentage was calculated as (massfat / (masslean + massfat)). 
Erectile Response Measurements 
 All rats were fasted overnight prior to erectile function studies. Rats were anesthetized 
with an intraperitoneal injection of 90 mg/kg ketamine and 10 mg/kg xylazine, and supplemented 
with an intramuscular injection as needed. The left carotid artery was cannulated with a 20-gauge 
needle connected via polyethylene (PE) tubing to a pressure transducer, anti-coagulated with 2.0 
U/ml heparinized saline allowing for continuous measurement of systemic blood pressure and 
intra-arterial administration of saline. The shaft of the penis was freed of skin and fascia and the 
right corpus cavernosum cannulated with a 27-gauge needle connected via PE tubing to a 
pressure transducer, and the left corpus cavernosum cannulated with a 27-gauge needle 
connected via PE tubing to a syringe containing heparinized saline. The abdominal cavity was 
opened and the right major pelvic ganglion (MPG) exposed. Platinum bipolar electrodes attached 
29 
 
to a Grass Stimulator (Grass S09, Grass Technologies, West Warwick, RI) were positioned near 
the MPG on the cavernosal nerve to deliver electrical field stimulation (EFS), consisting of a 
series of 1-5 volts for 30 seconds at each voltage, delivered in 5-millisecond pulses at a 
frequency of 13 Hz (132). Mean arterial pressure (MAP) and intracavernosal pressure (ICP) were 
recorded throughout each voltage series with LabChart 7 software (ADInstruments, Sydney, 
Australia). Three voltage series’ were conducted and averaged as the erectile response. ICP 
returned to baseline between each series. Following the three voltage series’, either 12 µl of 10 
µM sepiapterin (Cayman Chemical, Ann Arbor, MI) dissolved in heparinized saline, or 12 µl of 
1 mM apocynin was injected into the left corpus cavernosum. A voltage series was conducted 
30-minutes post-injection for sepiapterin, or 20-minutes post-injection for apocynin where 
treatment effects were maximal. 
Coronary Artery Endothelium-Dependent and -Independent Vasodilation 
 Immediately following the erection surgery, rats were euthanized by exsanguination and 
double pneumothorax. Hearts were excised and four segments (0.3 – 0.8 mm) of the left anterior 
descending coronary artery were carefully dissected and freed from adhering myocardium. Two, 
40 µm diameter, stainless steel wires were passed through each arterial segment and mounted in 
a multi wire myograph (DMT 620 M, Aarhus, Denmark). Vessel segments equilibrated for 45 
minutes bathed in physiological saline solution (PSS) at pH 7.4, 37°C, gassed with medical grade 
air as described (132). The relationship between passive wall tension and internal circumference 
was determined for each segment, from which the internal circumference (L100) corresponding to 
a transmural pressure of 100 mmHg for a relaxed vessel in situ was calculated. Vessels were set 
to an internal circumference equal to 0.9 times L100, at which tension development is maximal in 
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these arteries (163). Vessels were allowed to equilibrate for another 45 minutes, and then 
challenged with 109 mM K
+
 physiological saline solution (KPSS) to test vessel viability. Vessels 
were depolarized for 10 minutes and relaxed with repeated washes of PSS at 10-minute intervals. 
Vessels were pre-constricted with 3.0 µM 5-hydroxytryptamine (5-HT), and endothelial function 
tested with cumulative doses of acetylcholine (ACh) (0.001 – 10.0 µM). Following 30 minutes of 
repeated washes of PSS at 10 minute intervals, vessel segments were incubated in either 300 µM 
apocynin or 10 µM sepiapterin for 30 minutes, and the ACh cumulative dose response following 
5-HT pre-constriction was repeated. Vessels were washed for 30 minutes with repeated washes 
of PSS at 10 minute intervals, and endothelium-independent relaxation was tested with 
cumulative doses of sodium nitroprusside (SNP) (0.0001 – 1.0 µM) following 5-HT pre-
constriction. 
Data and Statistical Analysis 
 The erectile response was calculated from the ratio of the average ICP divided by the 
average MAP during the final 25 seconds of each 30-second voltage stimulation level. The area-
under-the-curve (AUC) of all voltages for each voltage series was calculated by GraphPad Prism 
(Prism 5.0, GraphPad, San Diego, CA). Coronary artery endothelium-dependent and -
independent vasodilation was assessed by the average stress produced by each vessel in the final 
30 seconds of each dose. Vessel stress was calculated by subtracting basal vessel force produced 
from the force produced at each respective concentration and normalized to vessel surface area. 
The percent relaxation of 5-HT induced constriction at each concentration was calculated as: ((1-
(stressconcentration / stress5-HT))*100). The relaxation responses from the four vessel segments were 
averaged for each rat, and analyzed as a single observation. Concentration-response curves were 
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generated against the logarithm of each concentration, and fit by non-linear regression to 
generate EC50 values to describe each curve (GraphPad Prism v. 5.0). Data were presented as 
mean ± SEM.  Statistical analyses were performed with GraphPad Prism v. 5.0 or SPSS v. 19.0 
(IBM, Armonk, NY, USA) with an alpha level of 0.05. Statistical differences between groups 
were determined by one-way ANOVA with Tukey’s multiple comparisons post-hoc analysis for 
serum markers, EC50 values, and AUC values. Statistical differences between groups for the 
voltage-dependent erectile response, and concentration-response curves at each voltage or 
concentration were determined by two-way repeated measures ANOVA with Bonferroni’s post-
hoc analysis. Trends were determined by one-way ANOVA with a linear trend post-test in 
GraphPad Prism v. 5.0. 
Human Study 
Subjects 
 Young (age 18-41) men and women from Pitt County, a rural community of 
approximately 100,000 residents, were recruited to participate in this study. Subjects were 
recruited across a range of BMI from 18-40 kg/m
2
. Based on pilot data (Figure 11), subjects were 
divided into tertiles based on BMI. Divisions of lean and non-lean groups or of lean, overweight, 
and obese groups, were not made because those groupings were not congruent with the pilot data 
(Figure 11). Tertiles based on BMI were utilized to investigate group differences in 
microvascular endothelial function where ROS production was elevated. Tertile 1 included 
subjects with a BMI range of 18.6-25.0 kg/m
2
 (n = 7), tertile 2 included a BMI range of 28.3-
32.5 kg/m
2
 (n = 8), and tertile 3 included a BMI range of 33.0-40.4 kg/m
2
 (n = 7). Prior to 
initiation of the study, subjects were not involved in any physical activity program (> 4 METS 
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for > 30 minutes per day, > 1 day per week) for the past six months. All subjects were non-
smokers with no known history of cardiovascular disease. Subjects were excluded if they 
demonstrated a fasting blood glucose concentration greater than 125 mg/dl. Subjects were not 
taking any medications for hypertension, hypercholesterolemia, insulin resistance or non-insulin 
dependent diabetes mellitus. Subjects abstained from antioxidant supplementation for the 
duration of the experimental period. All female subjects were on oral contraceptive medication. 
There were no restrictions with regard to race, gender, or socioeconomic status. All procedures 
were approved by the University and Medical Center Institutional Review Board of East 
Carolina University. 
Anthropometrics 
 Height was measured with a stadiometer to the nearest 0.1 cm. Body mass was measured 
with a digital electronic scale to the nearest 0.05 kg. BMI was calculated as body mass in 
kilograms divided by height in meters squared (kg/m
2
). Body fat percentage was determined 
using dual-energy x-ray absorptiometry (DXA; GE Lunar Prodigy Advance, Madison, WI, 
USA).  
Fasting blood glucose, insulin, and lipid profiles 
 Approximately 12 ml of blood was collected from an antecubital vein following an 
overnight fast in glass evacuated blood collection tubes (BD Medical Supplies, Franklin Lakes, 
NJ, USA). Blood samples were allowed to clot and then were centrifuged at 3300 rpm for 
approximately 10 minutes. Serum glucose, insulin, triglycerides (TG), total-cholesterol (TC), and 
high-density lipoprotein cholesterol (HDL-C) were assessed by a commercial clinical laboratory 
(Laboratory Corporation of America). Low density lipoprotein cholesterol (LDL-C) was 
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calculated by the Friedewald formula (164): LDL-C (mg/dl) = TC – HDL-C – (TG/5). The 
homeostatic model of insulin resistance (HOMA-IR) was calculated from fasting glucose and 
insulin concentrations as HOMA-IR = [Insulin (mU/l) * Glucose (mmol/l)]/22.5 (162). 
Insertion of microdialysis probes 
 Three microdialysis probes were inserted into the left vastus lateralis under sterile 
techniques as previously described (61, 165), while the subject is resting in a hospital bed. 
Following administration of local anesthesia (1 ml of 1% Lidocaine HCl) above the muscle 
fascia, an 18-gauge catheter (Jelco, Smiths Medical, Southington, CT, USA) surrounded by 
plastic introducer tubing was inserted into the vastus lateralis for each probe insertion. The 
catheters were then withdrawn, while the introducer tubing was left in the muscle. A 
microdialysis probe (CMA 20 Elite, CMA Microdialysis AB, Solna, Sweden) was then inserted 
into each of the three introducers. The splittable introducer tubing was then pulled out of the 
thigh, leaving the probes in place in the muscle. The distal 10 mm of the microdialysis probe 
contains a semi-permeable membrane allowing for bi-directional diffusion of small molecules (< 
20 kDa) and interaction of the perfusate with the local environment (< 1cm
3
). All probes were 
inserted at least 3 cm apart. Probes are then perfused with a 0.9% saline solution containing 5 
mM ethanol (EtOH) with microinfusion pumps (CMA 107, CMA/Microdialysis, Solna, Sweden) 
at a flow rate of 2.0 µl/min for the remainder of the experiment. Probes were perfused for 60 
minutes to allow for recovery from trauma induced by probe insertion. Following recovery from 
trauma, three-10 minute samples were collected from each probe in 150 µl polyethylene 
collection vials, which were capped and stored for analysis of baseline blood flow rates later that 
day. One probe had 300 µM apocynin added to the perfusate for the duration of the experiment 
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to test the impact of NADPH oxidase on ROS production and microvascular endothelial function 
(Table 4).  
In vivo ROS production 
 Fluorescence spectrometry of skeletal muscle extracellular ROS levels was performed 
using Amplex Ultrared (Molecular Probes, Eugene, OR, USA). Amplex Ultrared is a fluorogenic 
substrate with a very low background fluorescence which reacts with H2O2 with a 1:1 
stoichiometry to produce the highly fluorescent resorufin. 100 µM Amplex Ultrared and 1.0 
U/ml horseradish peroxidase (HRP; Sigma Aldrich, St. Louis, MO, USA) were added to the 
perfusate allowing H2O2 produced in vivo to cross over the membrane and react with the 
fluorogenic substrate within the microdialysis probe. Three-20 minute dialysate samples were 
collected in 150 µl collection vials wrapped in aluminum foil, and fluorescence intensity was 
measured immediately upon collection by a TD-700 laboratory fluorometer (Turner Designs, 
Sunnyvale, CA, USA) at an excitation wavelength of 550 nm and an emission wavelength of 570 
nm. 10 U/ml SOD (Sigma Aldrich, St. Louis, MO, USA) was then added to the perfusate 
allowing for the conversion of superoxide that crosses over the membrane to H2O2, which reacts 
with the fluorogenic substrate. One of the microdialysis probes contained 300 µM apocynin in 
the perfusion mixture (Table 4), allowing for the contribution of NADPH oxidase to ROS 
production to be assessed. Relative fluorescence units were converted to [H2O2], based on an 
[H2O2] standard curve conducted by addition of known concentrations of H2O2 to each perfusate 
following each experiment.   
Microvascular endothelial function 
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 Following assessment of ROS production, the perfusion media was changed on all three 
probes (Table 4). The new perfusates were composed of a 0.9% saline solution with 5 mM EtOH 
and one of the following three pharmacological agents: 1) 50 mM sodium nitroprusside to test 
the endothelium-independent vasodilatory response, 2) 50 mM acetylcholine to test the 
endothelium-dependent vasodilatory response, or 3) 50 mM acetylcholine + 300 µM apocynin to 
test the influence of NADPH oxidase on the endothelium-dependent vasodilatory response. 
Probes were perfused for 30 minutes to allow for equilibration, and three-10 minute samples 
were collected over the subsequent 30 minutes where the pharmacological response is maximal. 
Samples were stored in capped collection vials until analysis later that day. During perfusion, 
EtOH diffuses from the microdialysis membrane and away from the local area by the 
microcirculatory blood flow in the immediate vicinity of the microdialysis probe membrane. 
EtOH concentrations of the perfusate and dialysate were analyzed using an enzymatic-
fluorometric method based on the conversion of EtOH and NAD to acetaldehyde and NADH, as 
described (166). 2.0 µl of perfusate, dialysate, or standard were added to a reaction buffer 
consisting of 74 mM sodium pyrophosphate, 60 mM hydrazine sulfate, 22 mM glycine, and 500 
µM NAD. The reaction was then catalyzed by addition of 33.55 mU alcohol dehydrogenase. 
Samples were incubated in the dark for 60 minutes, and fluorescence was measured at excitation 
of 360 nm and emission of 415 nm. EtOH concentration was calculated based on an EtOH 
standard concentration curve. All samples and standards were measured in triplicate. The EtOH 
outflow-to-inflow ratio was calculated as [EtOH]dialysate/[EtOH]perfusate, which is inversely 
related to local blood flow in a non-linear fashion, and was converted to blood flow units 
(ml•min-1•100 g-1) using the equations of Wallgren et al (167).  
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Table 4. Microdialysis perfusion protocol 
  
Equilibrate  
0-60 min 
Phase 1 
(3 samples) 
60-90 min 
‡
 
Phase 2 
(3 samples) 
90-150 min 
Phase 3 
(3 samples) 
150-210 min 
 
Equilibrate 
210-270 min 
Phase 4 
(3 samples) 
270-300 min 
‡
 
Probe 1 Control Control Control
‡
 Control
‡
 SNP SNP 
Probe 2 Control Control Control* Control** ACh ACh 
Probe 3 Apocynin Apocynin Apocynin* Apocynin** ACh + 
Apocynin 
ACh + 
Apocynin 
 
* 100 µM amplex ultrared, 1 U/mL HRP added to perfusate to measure in vivo H2O2 production 
within the microdialysis probe. 
** 100 µM amplex ultrared, 1 U/mL HRP, 10 U/mL SOD added to perfusate. SOD will convert 
O2
·- 
that crosses the membrane into H2O2, which will react with amplex ultrared within the 
microdialysis probe. The difference in ROS between phases 2 and 3 is attributed to in vivo O2
·-
 
production. 
‡
 Ethanol o/i ratio measured to assess microvascular nutritive blood flow. 
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Aerobic interval training 
 Following the initial microdialysis session, subjects performed a standardized maximal 
exercise test to assess maximal aerobic capacity. A facemask was placed on the subject’s face to 
allow for expired O2 and CO2 to be continuously monitored via open circuit spirometry 
(TrueMax 2400; Parvomedics; Salt Lake City, UT, USA). VO2peak was assessed using the Storie 
protocol (Figure 1), a treadmill ramp protocol where the speed or incline is increased every two-
minutes until volitional fatigue is reached. Heart rate was recorded every minute throughout the 
test and immediately upon fatigue to determine the maximum heart rate (HRmax). Subjects then 
performed an aerobic interval training intervention, consisting of exercise three days per week 
for eight weeks. Exercise consisted of walking/running up an incline (7-12%) on a motor-driven 
treadmill. Subjects performed a 10-minute warm-up at ~60% HRmax, followed by four 4-minute 
intervals at 88-92% HRmax interspersed by 3-minute active recovery periods at ~70% HRmax. 
The intervals were followed by a 4-minute cool down at ~60% HRmax, yielding a total exercise 
time of 42 minutes per session. HR was monitored throughout each training session, and 
intensity (speed or incline) was increased when HR failed to reach at least 88% HRmax during the 
high-intensity interval. The fasting blood draw and microdialysis session was repeated two-days 
following the final training session to assess the impact of the aerobic interval training 
intervention on extracellular ROS production and microvascular endothelial function. The 
maximal exercise test and anthropometric tests were repeated following the final microdialysis 
session to test the impact the exercise intervention on maximal aerobic capacity and body 
composition.  
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Table 5. Storie treadmill test 
 
Subject: ____________________ Age: _______   Date:____________ 
Medications________________________________________________________________ 
Age-Predicted Maximum HR  100% ________________________ 85%____________________ 
Sitting:  HR ___________ BP_____/______/_______  Standing:  HR _______  BP _____/______ 
STAGE  SPEED GRADE   PRED. HR BP  RPE      COMMENTS 
   (min.)    (mph)     (%)       METS                 (signs/symptoms) 
0  3.0      0      3.0  ____    ______________ 
1  3.0      0      3.0  ____ ____/_____ ____ ______________ 
2  3.0      5            5.0  ____    ______________  
3  3.0      5      5.0  ____ ____/_____ ____ ______________ 
4  3.0    7.5        6.0  ____    ______________ 
5  3.0            7.5            6.0  ____ ____/_____ ____ ______________ 
6  3.0   10.0      7.0  ____    ______________ 
7  3.0           10.0      7.0  ____ ____/_____ ____ ______________ 
8  3.4   10.0          8.0  ____    ______________ 
9  3.4   10.0      8.0  ____ ____/_____ ____ ______________ 
10  3.4   12.0      9.0  ____    ______________ 
11  3.4   12.0      9.0  ____ ____/_____ ____ ______________ 
12  3.8   12.0     10.0  ____    ______________ 
13  3.8   12.0     10.0  ____ ____/_____ ____ ______________ 
14  4.0   12.0     11.0  ____    ______________ 
15  4.0      12.0     11.0  ____ ____/_____ ____ ______________ 
16  5.0     9.5     12.0  ____    ______________ 
17  5.0     9.5     12.0  ____ ____/_____ ____ ______________ 
18  5.5     9.5     13.0  ____    ______________ 
19  5.5     9.5     13.0  ____ ____/_____ ____ ______________ 
20  5.9     9.5     14.0  ____    ______________ 
21  5.9     9.5     14.0  ____ ____/_____ ____ ______________ 
22  6.4     9.5     15.0  ____    ______________ 
23  6.4     9.5     15.0  ____ ____/_____ ____ ______________ 
 
 
 
 
 
Comments:  
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Data and statistical analyses 
 Subjects were divided into tertiles based off of BMI. Statistical differences between 
tertiles for metabolic parameters, ROS production, and ACh- or SNP-stimulated blood flow were 
assessed by one-way ANOVA with a Newman-Keuls post hoc analysis. Treatment effects of 
apocynin were determined with a two-way repeated measures ANOVA with a Bonferroni post 
hoc analysis. Differences in response to apocynin treatment across tertiles were determined with 
tertile by apocynin interaction effects of a two-way repeated measures ANOVA. Due to a drop-
out or incompletion rate of 59% during the exercise intervention, tertiles 1 and 2 were combined 
because they were not different prior to training with respect to any main outcome measure. For 
all pre-to-post training comparisons, only data of subjects that completed the training program 
were included in the pre-training values. Training induced changes in metabolic parameters were 
determined within each group by a paired t-test. Exercise training induced changes in ROS 
production, ACh-stimulated blood flow, and SNP-stimulated blood flow within each group were 
determined by a paired t-test. Training induced changes in the effects of apocynin treatment were 
determined with a two-way repeated measures ANOVA. Due to low statistical power for 
exercise training effects, the effect size of all main outcome measures were calculated as: 
[(Mean1 – Mean2)/pooled standard deviation]. Effect sizes > 0.5 were considered medium effect 
sizes. Effect sizes > 0.8 were considered large effect sizes. Statistical analyses were performed 
with GraphPad Prism v. 5.0 or SPSS v. 19.0 with an alpha level of 0.05. 
 
 
CHAPTER 4: RESULTS 
Animal Study: Aim 1 
Metabolic Parameters  
 There were no statistically significant increases in body weight or composition in 
response to the WD (Table 6). Fasting blood glucose was significantly elevated in rats fed the 
WD for 12 weeks compared to all other groups. Despite increased glucose, no significant 
differences existed for insulin or HOMA-IR between groups (Table 6). There were no apparent 
differences in serum lipid profiles between the control diet and WD groups (Table 6). There was 
a trend for increasing serum HNE adducts with increasing diet duration (P = 0.028), suggesting 
increased lipid peroxidation and systemic oxidative stress in the 8-week and 12-week WD fed 
rats (Table 6).
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Table 6 Aim 1 Metabolic Parameters. 
 
 
Control 4-week 8-week 12-week 
ANOVA 
P-value 
Body Weight (g) 443 ± 12.2 478 ± 8.0 453 ± 13.6 489 ± 12.8 0.059 
Fat Mass (g) 50.0 ± 1.59 56.5 ± 6.0 67.8 ± 10.9 73.4 ± 4.2 0.226 
Lean Mass (g) 329 ± 10.8 355 ± 2.9 326 ± 7.8
†
 350 ± 10.3 0.018 
Body Fat % 13.2 ± 0.47 13.6 ± 1.25 19.9 ± 2.10 17.3 ± 0.94 0.241 
Glucose (mg/dl) 115 ± 2.9 105 ± 4.8 110 ± 3.3 131 ± 3.5
*,†,‡
 0.001 
Insulin (pmol/l) 126.7 ± 33.4 87.1 ± 15.0 159.8 ± 30.4 155.8 ± 14.0 0.320 
HOMA-IR 5.06 ± 1.36 3.19 ± 0.66 6.03 ± 1.09 7.02 ± 0.62 0.207 
Triglycerides (mg/dl) 52.3 ± 14.9 45.9 ± 14.1 38.8 ± 6.95 28.8 ± 6.9 0.597 
Cholesterol (mg/dl) 32.3 ± 3.47 27.9 ± 2.96 38.8 ± 2.76
†
 31.4 ± 1.72 0.059 
HDL-C (mg/dl) 22.4 ± 2.78 21.6 ± 1.61 30.9 ± 2.63
†
 24.9 ± 1.40 0.020 
LDL-C (mg/dl) 7.0 ± 0.45 7.7 ± 0.86 8.5 ± 0.24 8.7 ± 0.55 0.202 
HNE-adducts 0.695 ± 0.09 0.752 ± 0.23 0.976 ± 0.14 1.20 ± 0.15 0.095 
 
 
Values are means ± SEM, N = 3-8 animals per group. 
*
 P < 0.05 vs. Control, 
†
 P < 0.05 vs. 4-
week, 
‡
 P < 0.05 vs. 8-week. 
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Voltage-Dependent Erectile Response 
 Erectile function was assessed by measuring the AUC of the voltage-dependent erectile 
response, suggestive of the ability to achieve and maintain an erection upon electrical field 
stimulation. The AUC was significantly depressed following 8 weeks of the Western diet, and 
remained similarly depressed following 12 weeks of the Western diet (Figure 1A). The 
ICP/MAP in response to the intermediate voltages (2V and 3V) of stimulation were significantly 
attenuated following 8 and 12 weeks of the WD (Figure 2). Intracavernosal treatment with 
sepiapterin had no effect on the voltage-dependent erectile response of control diet rats, but 
significantly augmented the erectile response of all groups of WD fed rats (Figure 3). The 
ICP/MAP following sepiapterin treatment was increased in response to 3V of stimulation was 
increased in 4-week (Figure 3B) and 8-week (Figure 3C) WD fed rats, and in response to 4V of 
stimulation in 12-week WD fed rats (Figure 3D).  
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Figure 1 Rats developed erectile dysfunction prior to coronary artery endothelial dysfunction in 
response to a Western diet.  (A) The area under the curve (AUC) of all voltages of the voltage-
dependent erectile response was attenuated 8 weeks into the Western diet. (B) ACh-stimulated 
vasodilation of the coronary artery was attenuated 12 weeks following initiation of the Western 
diet (elevated EC50). * P < 0.05 vs. Control group, ** P <  0.01. Reported are means ± SEM for 
5-7 animals in each group. 
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Figure 2 Voltage-dependent erectile response following control diet or Western diet for 4, 8, or 
12 weeks. ICP/MAP was reduced at 2 and 3 volts in the 8-week (hatched bars) and 12-week 
(open bars) Western diet fed rats compared to control diet fed rats (black bars). Reported are 
means ± SEM for 5-7 animals in each group; 
*
 P < 0.05, 
†
 P < 0.01 vs. Control. 
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Figure 3 Effect of sepiapterin on voltage-dependent erectile response. Following the untreated 
voltage series’ (open bars), 10 µM sepiapterin was injected intracavernosally and a voltage series 
was applied 30-minutes post-injection (hatched bars). No treatment effects were observed in rats 
fed the control diet (A), while rats fed the Western diet for 4 weeks (B), 8 weeks (C), and 12 
weeks (D) demonstrated an enhanced erectile response with sepiapterin treatment. * P < 0.05, 
*** P <  0.001. Reported are means ± SEM for 4-6 animals in each group. 
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Coronary Artery Endothelium-Dependent and -Independent Relaxation 
 Coronary artery endothelial function was assessed from the concentration-response to the 
endothelium-dependent agonist acetylcholine. The effective concentration producing 50% of a 
maximal relaxation response (EC50) following pre-constriction was used to assess sensitivity to 
acetylcholine, and thus the ability of the endothelium to produce nitric oxide. The EC50 of the 
acetylcholine response was significantly elevated in 12-week Western diet fed rats compared to 
all other groups (Figure 1B). The ACh-induced relaxation curves are plotted in Figure 4A, where 
the relaxation profile was significantly attenuated at a single concentration for the 8-week WD 
rats and at three concentrations for the 12-week WD rats when compared to the relaxation 
profiles of control diet rats. There were no significant differences in the Hill-slope for the ACh 
response (Control: 1.01 ± 0.23; 4-wk: 0.96 ± 0.16; 8-wk: 1.01 ± 0.21; 12-wk: 0.64 ± 0.09; P = 
0.522). Coronary artery endothelium-independent relaxation was assessed from the 
concentration-response profile to the NO donor sodium nitroprusside. There were no significant 
differences between groups for the relaxation response to SNP (Figure 4B), indicating no diet-
induced differences in vessel response to NO. There were no significant differences for the EC50 
(Control: 25.1 ± 0.23 nM; 4-wk: 21.7 ± 6.8 nM; 8-wk: 19.9 ± 8.6 nM; 12-wk: 14.5 ± 6.0 nM; P = 
0.821) or the Hill-slope (Control: 1.48 ± 0.18; 4-wk: 1.45 ± 0.24; 8-wk: 1.47 ± 0.24; 12-wk: 1.54 
± 0.16; P = 0.994) values for the SNP response. 
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Figure 4 Mean concentration-response of left-anterior descending coronary artery segments 
following 3.0 µM 5-HT pre-constriction to (A) acetylcholine stimulation (0.001 – 10.0 µM) or 
(B) sodium nitroprusside stimulation (0.001 – 1.0 µM) in rats exposed to the control diet or 
Western diet for 4, 8, or 12 weeks. Reported are means ± SEM for 5-7 animals in each group. 
†
 P 
< 0.05 8-week vs. Control, 
*
 P < 0.05 12-week vs. Control, 
***
 P < 0.001 12-week vs. Control. 
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Animal Study: Aim 2 
Metabolic Parameters 
 The body weight from the CD-Ex rats was significantly lower than WD-Sed, however 
WD-Sed rats had significantly more fat mass than any other group while lean mass was not 
different among any group (Table 7). Despite increased glucose in the WD-Sed rats, no 
differences in insulin, HOMA-IR or HOMA-Beta (Table 7) were observed between groups.  
WD-Ex rats had lower total cholesterol levels than CD-Sed rats, while no differences existed for 
HDL-cholesterol, LDL-cholesterol, or triglyceride levels between groups (Table 7). 
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Table 7 Aim 2 Metabolic Parameters 
 
CD - Sed CD - Ex WD - Sed WD - Ex 
ANOVA 
P-value 
Body Weight (g) 458 ± 8.0 424 ± 12.5 499 ± 11.1† 456 ± 17.2 0.003 
Fat Mass (g) 52.0 ± 5.97 34.8 ± 7.48 76.9 ± 4.93
*,†,‡
 44.3 ± 8.48 0.001 
Lean Mass (g) 341 ± 6.1 328 ± 7.8 356 ± 8.3 349 ± 10.3 0.154 
Body Fat % 13.1 ± 1.30 9.3 ± 1.82 17.7 ± 0.98
†,‡
 10.9 ± 1.52 0.001 
Glucose (mg/dl) 107 ± 3.5 99 ± 1.6 121 ± 3.5
*,†
 109 ± 3.7 <0.001 
Insulin (pM) 125 ± 43.5 142 ± 28.1 174 ± 24.3 116 ± 23.4 0.482 
HOMA-IR 4.94 ± 1.84 4.87 ± 0.95 7.34 ± 1.04 4.51 ± 1.09 0.250 
HOMA-Beta 123 ± 36.5 197 ± 41.8 150 ± 21.7 123 ± 17.5 0.321 
Cholesterol (mg/dl) 39.0 ± 4.53
‡
 34.0 ± 2.59 30.2 ± 1.91 27.1 ± 2.14 0.029 
HDL-C (mg/dl) 25.9 ± 2.36 22.9 ± 2.24 24.6 ± 1.67 21.8 ± 1.80 0.542 
LDL-C (mg/dl) 8.6 ± 1.44 9.8 ± 0.66 7.7 ± 0.42 8.0 ± 0.50 0.129 
Triglycerides (mg/dl) 58.0 ± 9.8 54.8 ± 12.2 45.3 ± 10.0 27.3 ± 6.1 0.128 
 
Values are means ± SEM, N = 5-11 animals per group. 
*
 Significant vs. CD-Sed, 
†
 Significant vs. 
CD-Ex, 
‡
 Significant vs. WD-Ex. CD, Control diet; WD, Western diet; Sed, Sedentary; Ex, 
Exercise. 
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Voltage-Dependent Erectile Response 
 The ICP/MAP in response to the intermediate voltages (2, 3, and 4V) was significantly 
attenuated by the Western diet, and was preserved by exercise training within the Western diet 
(Figure 5). However, the ICP/MAP at 2 and 3V was significantly attenuated by exercise training 
within the control diet (Figure 5). Intracavernosal treatment with apocynin (Figure 6) or 
sepiapterin (Figure 7) had no effect on the voltage-dependent erectile response of the CD-Sed, 
CD-Ex, or WD-Ex rats, but significantly augmented the erectile response of WD-Sed rats.  
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Figure 5 Voltage-dependent erectile response. ICP/MAP was attenuated by the Western diet, 
which was prevented by exercise training. ICP/MAP was attenuated by exercise training within 
the control diet. Reported are means ± SEM for 8-11 animals in each group; 
**** 
P < 0.0001 CD-
Sed vs. WD-Sed, 
**
 P < 0.01 CD-Sed vs. WD-Sed, 
††††
 P < 0.0001 WD-Ex vs. WD-Sed, 
†† 
P < 
0.01 WD-Ex vs. WD-Sed, 
† 
P < 0.05 WD-Ex vs. WD-Sed, 
‡
 P < 0.05 CD-Sed vs. CD-Ex. 
§
 P < 
0.05 CD-Ex vs. WD-Sed. CD, control diet; WD, Western diet; Ex, exercise; Sed, sedentary. 
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Figure 6 Effect of acute apocynin administration on voltage-dependent erectile response. 
Following the untreated voltage series’ (open bars), 1 mM apocynin was injected 
intracavernosally and a voltage series was applied 20-minutes post-injection (hatched bars). No 
treatment effects were observed in control diet-sedentary (CD-Sed) (A), control diet-exercise 
(CD-Ex) (B), or Western diet-exercise (WD-Ex) (D), while apocynin enhanced the erectile 
response in Western diet-sedentary (WD-Sed) rats (C). Reported are means ± SEM for 4-5 
animals in each group 
**
 P < 0.01 vs. untreated. 
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Figure 7 Effect of acute sepiapterin administration on voltage-dependent erectile response. 
Following the untreated voltage series’ (open bars), 10 µM sepiapterin was injected 
intracavernosally and a voltage series was applied 30-minutes post-injection (checkered bars). 
No treatment effects were observed in control diet-sedentary (CD-Sed) (A), control diet-exercise 
(CD-Ex) (B), or Western diet-exercise (WD-Ex) (D), while sepiapterin enhanced the erectile 
response in Western diet-sedentary (WD-Sed) rats (C). Reported are means ± SEM for 4-6 
animals in each group 
*
 P < 0.05 vs. untreated. 
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Coronary Artery Endothelium-Dependent and -Independent Relaxation 
 The ACh-stimulated relaxation curves are presented in Figure 8A. The relaxation profile 
was significantly attenuated by the Western diet at two ACh concentrations. Similarly, exercise 
augmented the relaxation profile within the Western diet at two ACh concentrations. The 
coronary artery endothelium-independent relaxation was assessed from the concentration-
response profile to the NO donor sodium nitroprusside. There were no significant differences 
between groups for the relaxation response to SNP (Figure 8B), indicating no diet or exercise 
induced differences in vessel response to NO. Thus, the impaired ACh response in WD-Sed rats 
is likely a dysfunction of the endothelium via impaired NO production as the smooth muscle 
retains a normal relaxation response to a NO donor and activator of the cGMP mediated 
relaxation pathway. Treatment of the vessel segments with apocynin augmented ACh-stimulated 
vasorelaxation profile in WD-Sed, but had no significant effect on Con-Sed, Con-Ex, or WD-Ex 
coronary artery segments (Figure 9). Treatment with sepiapterin attenuated the ACh-stimulated 
vasorelaxation profile in Con-Sed, but had no significant effect on Con-Ex, WD-Sed, or WD-Ex 
coronary artery segments (Figure 10). 
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Figure 8 Mean concentration-response of coronary artery segments following 3.0 µM 5-HT pre-
constriction to (A) acetylcholine (ACh) stimulation (0.001 – 10.0 µM) or (B) sodium 
nitroprusside (SNP) stimulation (0.0001 – 1.0 µM). Mean ACh-response EC50 values were: 
0.111 µM (CD-Sed), 0.150 µM (CD-Ex), 0.283 µM (WD-Sed), 0.116 µM (WD-Ex). Mean SNP-
response EC50 values are: 16.1 nM (CD-Sed), 15.5 nM (CD-Ex), 12.7 nM (WD-Sed), 24.1 nM 
(WD-Ex). Reported are means ± SEM for 6-11 animals in each group. 
***
 P < 0.001 CD-Sed vs. 
WD-Sed,
*
 P < 0.05 CD-Sed vs. WD-Sed, 
†
 P < 0.05 WD-Ex vs. WD-Sed. CD, control diet; WD, 
Western diet; Ex, exercise; Sed, sedentary. 
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Figure 9 Effect of apocynin on acetylcholine (ACh)-stimulated vasorelaxation of coronary artery 
segments. Vasorelaxation was examined in the absence (closed circles) and presence (open 
circles) of 300 µM apocynin. No treatment effects were observed in control diet-sedentary (CD-
Sed) (A), control diet-exercise (CD-Ex) (B), or Western diet-exercise (WD-Ex) (D), while 
apocynin enhanced ACh-stimulated vasorelaxation in Western diet-sedentary (WD-Sed) rats (C). 
Mean response EC50 values are: 0.126 vs. 0.118 µM (CD-Sed), 0.135 vs. 0.085 µM (CD-Ex), 
0.226 vs. 0.092 µM (WD-Sed), 0.142 vs. 0.145 µM (WD-Ex), untreated vs. apocynin, 
respectively. Reported are means ± SEM for 6-10 animals in each group 
*
 P < 0.05 vs. untreated. 
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Figure 10 Effect of sepiapterin on acetylcholine (ACh)-stimulated vasorelaxation of coronary 
artery segments. Vasorelaxation was examined in the absence (closed squares) and presence 
(open squares) of 10 µM sepiapterin. Sepiapterin treatment attenuated ACh-stimulated 
vasorelaxation in control diet-sedentary rats (A), while no treatment effects were observed in 
control diet-exercise (B), Western diet-sedentary (WD-Sed) (C), or Western diet-exercise (WD-
Ex) (D) rats. Mean response EC50 values are: 0.107 vs. 0.179 µM (CD-Sed), 0.176 vs. 0.252 µM 
(CD-Ex), 0.288 vs. 0.313 µM (WD-Sed), 0.157 vs. 0.305 µM (WD-Ex), untreated vs. 
sepiapterin, respectively. Reported are means ± SEM for 6-10 animals in each group 
*
 P < 0.05 
vs. untreated, 
***
 P < 0.001 vs. untreated. 
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Human Study: Aim 3 
Pilot Data 
 Pilot data was collected from lean (BMI < 25 kg/m
2
) and obese (BMI > 30 kg/m
2
) 
subjects. Measurement of in vivo ROS production is presented in Figure 11. There were no 
apparent differences in ROS production between lean subjects and those with a BMI ranging 
from 30.5-31.5 kg/m
2
 (P = 0.894). However, there was an apparent elevation in ROS production 
in subjects with a BMI ranging from 33-38 kg/m
2
 compared to lean subjects and subjects with a 
BMI from 30.5-31.5 kg/m
2
 (Figure 11).  
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Figure 11 Pilot data of in vivo ROS production in lean subjects (BMI < 25, n = 5), subjects with 
a BMI of 30.5-31.5 (n = 3), and subjects with a BMI of 33-38 (n = 4). ROS was measured via 
Amplex Ultrared fluorescence in the absence of SOD (-SOD), indicative of endogenous H2O2 
that crosses the microdialysis membrane, and in the presence of SOD (+SOD), indicative of 
endogenous H2O2 that crosses the microdialysis membrane and superoxide that crosses the 
microdialysis membrane and is converted to H2O2 within the membrane. Values are mean ± 
SEM. SOD, superoxide dismutase; H2O2, hydrogen peroxide.  
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Subject Characteristics and Metabolic Parameters 
 Subjects in tertile 2 were older than tertile 1 (P < 0.05), while there was no significant age 
difference between tertile 1 and tertile 3 (Table 8). There was a progressive increase in body fat 
percentage across the BMI tertiles (P < 0.001). Despite increased adiposity, there were no 
significant differences between tertiles in fasting blood glucose or insulin concentrations, 
corresponding to no significant differences in HOMA-1 (Table 8). Additionally, there were no 
significant differences between tertiles in fasting triglycerides, total-cholesterol, LDL-
cholesterol, or HDL-cholesterol (Table 8). There were no significant differences between tertiles 
in absolute VO2peak, but a significant decrease in VO2peak relative to body mass across the tertiles 
(P < 0.001, Table 8).  
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Table 8 Subject characteristics and metabolic parameters of each BMI tertile 
 
1 2 3 P-Value 
Age (years) 22.4 ± 0.56 29.7 ± 2.87
*
 24.1 ± 1.23 0.038 
Height (cm) 174 ± 3.15 176 ± 3.03 167 ± 3.25 0.141 
Weight (kg) 66.7 ± 4.76 95.6 ± 4.22
*
 105.9 ± 5.70
*
 <0.001 
BMI (kg/m
2
) 21.9 ± 1.00 30.6 ± 0.53
*
 37.6 ± 1.01
*,†
 <0.001 
Body Fat % 22.6 ± 3.07 36.0 ± 1.90
*
 47.2 ± 0.91
*,†
 <0.001 
Glucose (mg/dl) 84.7 ± 3.41 92.6 ± 2.23 90.4 ± 2.67 0.147 
Insulin (µIU/ml) 6.62 ± 1.34 16.3 ± 5.20 14.4 ± 2.67 0.220 
HOMA-IR 1.40 ± 0.30 3.84 ± 1.37 3.31 ± 0.70 0.248 
Triglycerides (mg/dl) 93.0 ± 8.1 113.4 ± 22.2 82.6 ± 13.7 0.428 
Total-Cholesterol (mg/dl) 163.8 ± 15.4 159.8 ± 8.8 160.6 ± 13.2 0.972 
HDL-Cholesterol (mg/dl) 54.3 ± 7.74 41.9 ± 3.53 48.0 ± 5.37 0.297 
LDL-Cholesterol (mg/dl) 90.9 ± 10.4 95.3 ± 9.8 96.1 ± 13.3 0.946 
VO2peak (l/min) 2.62 ± 0.26 2.93 ± 0.30 2.42 ± 0.17 0.361 
VO2peak (ml • kg
-1
• min
-1
) 38.9 ± 2.02 30.1 ± 2.41
*
 22.7 ± 1.16
*,†
 <0.001 
 
Values are mean ± SEM. 
*
 P < 0.05 vs. tertile 1, 
†
 P < 0.05 vs. tertile 2. 
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In Vivo ROS Production 
 In vivo ROS production was measured with and without SOD added to the perfusate. 
Amplex ultrared fluorescence without SOD in the perfusate is indicative of H2O2 produced 
endogenously that crosses over the microdialysis membrane (Figure 12a). With SOD added to 
the perfusate, Amplex ultrared fluorescence is indicative of H2O2 produced endogenously that 
crosses over the microdialysis membrane in addition to H2O2 produced inside the microdialysis 
probe by SOD from superoxide that crosses over the microdialysis membrane (Figure 12b). 
Endogenous H2O2 production was not significantly different across tertiles (P = 0.067). 
However, there was a significant tertile*apocynin interaction effect (P = 0.049), indicating a 
greater effect of NADPH oxidase inhibition on H2O2 production in tertile 3. Post hoc analysis 
indicates that H2O2 production was significantly reduced when apocynin was added to the 
perfusate in tertile 3 (P < 0.001). With SOD added to the perfusate, there was significant effect of 
BMI on ROS production (P = 0.030). Post hoc analysis indicates that ROS production was 
significantly (P < 0.05) increased in tertile 3 compared to both tertile 1 and tertile 2 (Figure 12b). 
There was a significant tertile*apocynin interaction effect (P = 0.023), indicating a greater effect 
of NADPH oxidase inhibition on combined H2O2 and superoxide production in tertile 3. Post hoc 
analysis indicates that ROS production is significantly reduced when apocynin is added to the 
perfusate in tertile 3 (Figure 12b; P < 0.01).  
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Figure 12 In vivo reactive oxygen species (ROS) production was measured in the absence 
(control, open bars) and presence of apocynin (closed bars), an NADPH oxidase inhibitor. In 
vivo ROS production was measured without superoxide dismutase (SOD) added to the perfusate, 
which is indicative of H2O2 produced endogenously that crosses over the microdialysis 
membrane (A). ROS detected with SOD added to the perfusate is indicative of H2O2 produced 
endogenously that crosses over the microdialysis membrane in addition to H2O2 produced inside 
the microdialysis probe by SOD from superoxide that crosses over the microdialysis membrane 
(B). Endogenous H2O2 production was not significantly different across tertiles (P = 0.067), 
while combined H2O2 and superoxide production were significantly elevated in tertile 3. 
Addition of apocynin to the perfusate significantly attenuated ROS production in tertile 3. Values 
are mean ± SEM for n = 7, 8, 7 subjects in tertiles 1,2, and 3, respectively. † P < 0.05 vs. tertile 
1. ‡ P < 0.05 vs. tertile 2. # Significant (P < 0.05) tertile*apocynin interaction effect. ** 
Significant treatment effect of apocynin (P < 0.01). *** Significant treatment effect of apocynin 
(P < 0.001).  
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Microvascular Blood Flow Responses 
 Microvascular endothelial function was assessed by measurement of ACh-stimulated 
blood flow. The impact of NADPH oxidase on microvascular endothelial function was assessed 
by co-perfusion of ACh and apocynin (Figure 13). ACh-stimulated blood flow was significantly 
depressed in tertile 3 (P = 0.011). Post hoc analysis indicates that ACh-stimulated blood flow 
was significantly decreased compared to tertile 1 (P < 0.05) and tertile 2 (P < 0.05). There were 
no significant differences in ACh-stimulated blood flow between tertile 1 and tertile 2. There 
was a significant tertile*apocynin effect on ACh-stimulated blood flow (P = 0.048), indicating an 
increase in ACh-stimulated blood flow with apocynin that is specific to tertile 3 (Figure 13). 
Microvascular endothelial function was further probed by perfusion of SNP, a direct NO donor 
and activator of the cGMP pathway (Figure 14). There were no significant differences in SNP-
stimulated blood flow across tertiles (P = 0.489). There were also no significant differences 
across tertiles in basal, non-stimulated blood flow (P = 0.201, Figure 14).  
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Figure 13 The effect of BMI and apocynin, an NADPH oxidase inhibitor, on microvascular 
endothelial function assessed by acetylcholine (ACh)-stimulated blood flow. ACh-stimulated 
blood flow was depressed in tertile 3. Apocynin augmented ACh-stimulated blood flow only in 
tertile 3. Values are mean ± SEM for n = 7, 8, 7 subjects in tertiles 1,2, and 3, respectively. † P < 
0.05 vs. tertile 1. ‡ P < 0.05 vs. tertile 2. # Significant (P < 0.05) tertile*apocynin interaction 
effect.  
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Figure 14 Effect of BMI on basal blood flow and endothelium independent vasodilation. There 
were no differences in basal, non-stimulated blood flow across BMI tertiles. Stimulation of blood 
flow independent of the endothelium was assessed by perfusion of sodium nitroprusside (SNP). 
There were no differences in SNP-stimulated blood flow across BMI tertiles. Values are mean ± 
SEM for n = 7, 8, 7 subjects in tertiles 1,2, and 3, respectively.  
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Effects of Exercise Training Intervention on Metabolic Parameters 
 Due to a subject drop-out rate that was higher than anticipated and no significant pre-
training differences in ROS production or microvascular endothelial function between tertiles 1 
and 2, the exercise training responses for tertiles 1 and 2 were combined to compare to tertile 3. 
There were no significant effects of the aerobic interval training intervention on body weight, 
glucose, insulin, blood lipid profile, or peak aerobic capacity (Table 9).  
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Table 9 Effect of exercise intervention on metabolic parameters 
 
Tertiles 1 & 2 Tertile 3 
 
Pre-training Post-training P Pre-training Post-training P 
BMI (kg/m
2
) 25.6 ± 2.85 25.5 ± 3.02 0.953 36.0 ± 1.17 36.0 ± 1.16 0.945 
Body Fat % 28.2 ± 5.83 27.8 ± 5.97 0.454 46.6 ± 2.06 47.0 ± 1.31 0.692 
Glucose (mg/dl) 87.6 ± 5.12 84.4 ± 4.41 0.378 90.0 ± 4.10 97.0 ± 4.08 0.063 
Insulin (µIU/ml) 6.42 ± 1.69 7.44 ± 2.60 0.776 11.8 ± 3.49 17.4 ± 3.04 0.090 
HOMA-IR 1.42 ± 0.42 1.62 ± 0.59 0.808 2.71 ± 0.92 4.24 ± 0.89 0.068 
Triglycerides (mg/dl) 68.6 ± 4.96 58.8 ± 7.22 0.359 91.8 ± 17.3 113 ± 25.9 0.185 
Total-Cholesterol (mg/dl) 156 ± 15.1 156 ± 17.8 0.995 165 ± 19.9 163 ± 14.2 0.844 
HDL-Cholesterol (mg/dl) 50.4 ± 9.57 50.6 ± 6.47 0.980 43.3 ± 3.17 37.8 ± 2.29 0.163 
LDL-Cholesterol (mg/dl) 92.3 ± 14.0 93.8 ± 20.7 0.962 104 ± 14.4 103 ± 8.24 0.920 
VO2peak (l/min) 2.41 ± 0.28 2.76 ± 0.33 0.064 2.71 ± 0.33 3.06 ± 0.22 0.240 
VO2peak (ml • kg
-1• min-1) 31.3 ± 3.93 35.3 ± 3.13 0.163 25.2 ± 0.58 29.1 ± 2.78 0.225 
 
Values are mean ± SEM for 5 subjects in tertiles 1 & 2, and 4 subjects in tertile 3.   
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Effects of Exercise Training Intervention on in vivo ROS Production 
There were no significant training induced changes in H2O2 production (P = 0.09; effect 
size = 0.837; Figure 15a) or H2O2 that is not blocked by apocynin (P = 0.852; effect size 0.145; 
Figure 15a) in tertiles 1 and 2. There was no significant training*apocynin interaction on H2O2 
production in tertiles 1 and 2 (P = 0.100; Figure 15a). Similarly, there were no significant 
training induced changes in combined H2O2 and superoxide production (P = 0.065; effect size = 
0.714; Figure 15c) or combined H2O2 and superoxide production that is not blocked by apocynin 
(P = 0.910; effect size = 0.090; Figure 15c) in tertiles 1 and 2. There was no significant 
training*apocynin interaction on combined H2O2 and superoxide production in tertiles 1 and 2 (P 
= 0.261; Figure 15c). There was no significant training induced change in H2O2 production (P = 
0.416; effect size = 0.702; Figure 15b) in tertile 3, however, there was a significant training 
induced increase in H2O2 production that is not blocked by apocynin (P = 0.035; effect size = 
1.393; Figure 15b). There was no significant training*apocynin interaction on H2O2 production 
(P = 0.315; Figure 15c). Similarly, there was no significant training induced change in combined 
H2O2 and superoxide production (P = 0.797; effect size = 0.268; Figure 15d) in tertile 3, 
however, there was a significant increase in combined H2O2 and superoxide production (P = 
0.015, effect size = 1.383, Figure 15d). There was no significant training*apocynin interaction on 
combined H2O2 and superoxide production in tertile 3 (P = 0.670; Figure 15d).  
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Figure 15 In vivo reactive oxygen species (ROS) production was measured before (Pre) and 
after (Post) the exercise training intervention, in the absence (control, open bars) and presence of 
apocynin (closed bars), an NADPH oxidase inhibitor. In vivo ROS production was measured 
without superoxide dismutase (SOD) added to the perfusate, which is indicative of H2O2 
produced endogenously that crosses over the microdialysis membrane (A, C). ROS detected with 
SOD added to the perfusate is indicative of H2O2 produced endogenously that crosses over the 
microdialysis membrane in addition to H2O2 produced inside the microdialysis probe by SOD 
from superoxide that crosses over the microdialysis membrane (B, D). There were no significant 
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training induced changes in ROS production in either tertile 1 and 2 or tertile 3. There was a 
significant training induced increase in H2O2 (B) and combined H2O2 and superoxide (D) that 
was not blocked by apocynin, suggesting an increase in non-apocynin inhibitable ROS 
production with exercise training. † P < 0.05 vs. pre-training apocynin. Values are mean ± SEM 
for 5 subjects in tertiles 1 and 2, and 4 subjects in tertile 3.  
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Effects of Exercise Training on Microvascular Blood Flow Responses 
 There were no significant effects of the exercise training intervention on ACh-stimulated 
blood flow (P = 0.889; effect size = 0.079; Figure 16a) or ACh-stimulated blood flow in the 
presence of apocynin (P = 0.370; effect size = 0.460; Figure 16a) in tertiles 1 and 2. There was 
no significant training*apocynin interaction effect (P = 0.388) in tertiles 1 and 2. There was a 
significant increase in ACh-stimulated blood flow in the absence of apocynin (P = 0.034; effect 
size 1.19; Figure 16b) following the exercise intervention in tertile 3. There was no significant 
effect of exercise training on ACh-stimulated blood flow in the presence of apocynin (P = 0.932; 
effect size 0.091; Figure 16b). There was no significant training*apocynin interaction effect (P = 
0.257) in tertile 3. There were no significant effects of exercise training on SNP-stimulated blood 
flow in tertiles 1 and 2 (P = 0.661; effect size = 0.197; Figure 17) or in tertile 3 (P = 0.302; effect 
size = 1.00; Figure 17).  
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Figure 16 Microvascular endothelial function was assessed by acetylcholine (ACh)-stimulated 
blood flow before (Pre) and after (Post) an 8-week aerobic interval training intervention. ACh-
stimulated blood flow assessments were made in the absence and presence of apocynin (Apo), an 
NADPH oxidase inhibitor. There were no significant effects of exercise training in tertiles 1 and 
2 (A). There was a significant increase in ACh-stimulated blood flow in tertile 3 following 
exercise training (B). There were no significant effects of apocynin or training*apocynin 
interaction effects in either group. * P < 0.05 vs. pre-training. Values are mean ± SEM for 5 
subjects in tertiles 1 & 2 and 4 subjects in tertile 3.  
  
74 
 
 
Figure 17 Endothelium independent dilation was assessed by sodium nitroprusside (SNP)-
stimulated blood flow before (Pre) and after (Post) an 8-week aerobic interval training 
intervention. There were no significant effects of exercise training on SNP-stimulated blood flow 
in tertiles 1 & 2 or tertile 3. Values are mean ± SEM for 5 subjects in tertiles 1 & 2 and 4 
subjects in tertile 3.
 
 
CHAPTER 5: DISCUSSION 
 In the collective work of this dissertation, we demonstrated that erectile dysfunction 
precedes coronary artery endothelial dysfunction in response to a high-fat, high-sucrose, Western 
pattern diet. Additionally, we demonstrated that diet-induced erectile dysfunction was partially 
reversed by acute apocynin or sepiapterin administration, while diet-induced coronary artery 
endothelial dysfunction was reversed by acute apocynin incubation. Furthermore, we 
demonstrated that an aerobic interval training intervention prevented both diet-induced erectile 
dysfunction and coronary artery endothelial dysfunction. We also developed a novel 
microdialysis method to detect in vivo extracellular reactive oxygen species production in human 
skeletal muscle, where we observed elevated reactive oxygen species production in individuals 
with a body mass index of 33 or greater. The increased reactive oxygen species production in 
these individuals was completely driven by NADPH oxidase. Furthermore, impaired skeletal 
muscle microvascular endothelial function was observed in the individuals with a body mass 
index greater than 33, which was also mediated by NADPH oxidase.  
Addressing specific aim 1, we investigated the time course of development of erectile 
dysfunction and coronary artery endothelial dysfunction in response to a Western diet that is high 
in sucrose and fat derived from saturated and n-6 poly-unsaturated fatty acids. Rats demonstrated 
an impaired erectile response to electrical field stimulation of the cavernosal nerve near the 
major pelvic ganglion following eight weeks of the Western diet, where an impaired coronary 
artery relaxation response to ACh followed at 12 weeks. Rats on this Western diet did not 
demonstrate severe increases in body weight or adiposity. The 12-week WD fed rats developed 
significantly higher fasting blood glucose levels; however, there were no severe elevations of 
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insulin resistance or evidence of dyslipidemia. The 8-week and 12-week WD fed rats developed 
a trend for higher serum concentrations of HNE-adducts, suggesting elevated systemic oxidative 
stress. These findings indicate that chronic poor nutrition may supersede many of the traditional 
metabolic risk factors at predicting risk of ED and CAD development in this rodent model.  
 Consistent with the hypothesis that erectile dysfunction is an early indicator of future 
CAD, it is likely that a reduction in erectile function occurs prior to the onset of coronary 
endothelial dysfunction in the Zucker rat model, where obese Zucker rats (OZR) become diabetic 
and severely hyperlipidemic (132, 148, 149). In 17-18 week old lean (LZR) and OZR, there is a 
4-fold increase in the media:lumen ratio in the penile arteries of OZR compared to LZR, where 
no difference was observed in the coronary arteries (149). This finding indicates that 
atherosclerotic development occurs in the penile artery prior to the coronary artery, and reflects 
the state of endothelial function as the vasodilatory response to ACh in the OZR is attenuated in 
the penile artery but not the coronary artery (149). Oltman et al. (148) found similar results as 
there was no difference in the coronary vasodilatory response to ACh between LZR and OZR at 
16-24 weeks of age, where an impaired coronary vasodilatory response to ACh was apparent in 
OZR at 28-36 weeks of age. It is also likely that the reduction in penile artery endothelial 
dysfunction corresponds to erectile dysfunction as Wingard et al. (132) observed a reduction in 
ICP/MAP in OZR at 16-20 weeks of age. These findings in Zucker rats may translate to other 
models of obesity, as ten weeks of a 61.6% fat, lard-based diet attenuates ACh-stimulated 
vasodilatory response in the penile artery of Wistar rats (150), but not the coronary artery (151). 
In the present study, there were no substantial diet-induced differences in the coronary relaxation 
response to SNP, a direct NO donor and activator of the cyclic GMP mediated relaxation 
pathway. These findings are in contrast to those where the coronary dilatory response to SNP is 
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significantly augmented in response to a high-fat diet (151), suggestive of a sensitization to NO 
in diet-induce obesity. Considering the SNP response, the impaired relaxation response to ACh 
in the 12-week WD-fed rats is likely a dysfunction of the endothelium via impaired NO 
production as the smooth muscle retains a normal relaxation response to application of an NO 
donor. 
 Various high-fat or hypercholesterolemic diets have previously been employed to 
investigate erectile function, cavernosum dynamics, and biochemical characteristics. Feeding 
Sprague-Dawley rats a 2% cholesterol, 10% lard diet for 5-6 months has previously shown to 
attenuate the voltage-dependent erectile response, in addition to induction of cavernosal smooth 
muscle hyperplasia and a reduction in cavernosal endothelial cell content and nNOS positive 
nerve fibers (168-170). In a design similar to the present study, Xie et al (171) fed C57Bl6 mice 
a 45% fat diet for progressive durations and observed a progressive decline in ACh-mediated 
relaxation of cavernosal strips and cavernosal endothelial cell content with increased diet 
duration. Similarly, ApoE
-/-
 mice fed a hypercholesterolemic diet for progressive durations 
displayed a progressive decline in cavernosal nNOS content, eNOS Ser
1177
 phosphorylation, 
capillary density, and ACh-mediated relaxation of cavernosal strips with increased diet duration 
(172). In addition to decreased cavernosal strip endothelium dependent dilation, feeding ApoE
-/-
 
mice a hypercholesterolemic diet has promoted increased lipid peroxidation and superoxide 
production, as well as decreased NO production from cavernosal tissue (173). 
 Erectile dysfunction and CAD both have the common underpinnings of endothelial 
dysfunction. This study supports the notion that erectile dysfunction may be an early marker of 
cardiovascular risk, as has been proposed in several review articles (174-177). In a large clinical 
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study, Thompson et al (178) found that the association between ED and CVD was nearly 
identical to the risk associated with current smoking or family history of myocardial infarction, 
both of which have long been established as CVD risk factors. Presentation of ED may provide 
an opportune time-point for clinician intervention. Long-term weight loss interventions through 
increased physical activity and/or caloric restriction have proven successful at improving erectile 
function in obese men (123, 179). While it is logical that such lifestyle interventions initiated at 
the onset of ED would postpone, or perhaps prevent CAD development, future studies are 
necessary to establish these relationships. 
 Addressing specific aim 2, we investigated the impact of NADPH oxidase and indicators 
of BH4 content associated eNOS uncoupling on erectile dysfunction and coronary artery 
endothelial dysfunction in response to a 12 week Western diet that is high in sucrose and fat 
derived from saturated and n-6 poly-unsaturated fatty acids. Furthermore, we investigated the 
efficacy of an aerobic interval training intervention on prevention of diet-induced vascular 
dysfunctions. Rats demonstrated an impaired erectile response to electrical field stimulation of 
the cavernosal nerve near the major pelvic ganglion, and an impaired coronary artery relaxation 
response to ACh following the chronic Western diet, both of which were prevented by the 
exercise intervention. Inhibition of NADPH oxidase with apocynin significantly improved 
erectile function and coronary artery endothelial function in the Western diet-sedentary group, 
while having no impact in the control diet or exercised groups. In contrast, stimulation of 
intracellular BH4 production with sepiapterin significantly improved erectile function in the 
Western diet-sedentary group, but had no effect on coronary artery endothelial function. 
Sepiapterin treatment attenuated coronary artery endothelial function in the control diet-
sedentary group, while having no effect on the Western diet or exercised groups. These findings 
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indicate that erectile function and coronary artery endothelial function are commonly impaired 
by NADPH oxidase in a 12 week Western diet-induced obesity model. However, the sepiapterin 
data indicate that eNOS uncoupling has a greater effect on erectile dysfunction than coronary 
artery endothelial dysfunction in the Western diet-induced obesity model. 
  Several studies have demonstrated impaired aortic endothelial function in high-fat diet-
induced obese rats (39, 153), and  mice (155), as well as coronary artery endothelial dysfunction 
of mice (180) and pigs (6, 156). Elevated oxidative stress has been documented in these vascular 
tissues by increased levels of nitrotyrosine (39), while treatment with superoxide dismutase 
(SOD) (155) or the superoxide scavenger TEMPOL (180) were shown to reverse high-fat diet-
induced endothelial dysfunction. Furthermore, the NADPH oxidase subunits p47
phox
 and gp91
phox
 
were found to be elevated in these vascular tissues (153, 155, 180). 
 Similar to other vascular beds, oxidative stress has been demonstrated in cavernosal 
tissue of LDLR
-/-
 mice fed a hypercholesterolemic diet (138), cholesterol fed rabbits (145), and 
high-fat diet fed pigs (144). Increased cavernosal markers of oxidative stress have also been 
observed in other models that demonstrate ED, such as streptozotocin (STZ)-induced diabetic 
rats (129, 141, 142, 181), and angiotensin II supplemented hypertensive rats (134). Oxidative 
stress is a likely contributor to ED, as treatment with various antioxidants (141, 142) or 
transfection of SOD (129) normalize markers of cavernosal oxidative stress and augments 
cavernosal vasorelaxation in STZ-diabetic rats. Similarly, elevated NADPH oxidase has been 
implicated in the pathogenesis of ED. Elevated expression of NADPH oxidase subunits have 
been found to be elevated in cavernosal tissue of angiotensin II supplemented hypertensive rats 
(134), STZ-induced diabetic rats (181), and LDLR
-/-
 mice fed a hypercholesterolemic diet (138). 
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Furthermore, addition of apocynin to drinking water blunts NADPH oxidase subunit expression 
and restores the voltage dependent erectile response in hypertensive rats (134) and 
hypercholesterolemic mice (138), while apocynin incubation of isolated cavernosal strips of 
hypercholesterolemic rabbits partially restores the relaxation response to an ACh analog (145). 
The present study demonstrates the impact of NADPH oxidase mediated oxidative stress on 
obesity associated ED, as acute NADPH oxidase inhibition partially reverses ED.  
 One potentially vasodestructive consequence of elevated NADPH oxidase activity is the 
quenching of NO by superoxide, resulting in the production of peroxynitrite. Further, 
peroxynitrite may then deplete intracellular BH4 levels, by direct oxidation of BH4 to BH2 (92).  
Adequate presence of BH4 is a critical requirement for normal eNOS functioning, which acts to 
stabilize eNOS dimers and allows for the oxidation of L-arginine and the subsequent generation 
of NO (36). Destabilization of eNOS dimers through BH4 depletion results in “eNOS 
uncoupling”, where electron flow from NADPH through eNOS to O2 is not inhibited, but results 
in the formation of superoxide rather than NO (36). The resulting situation is a potential vicious 
cycle where NADPH oxidase activity is elevated in metabolic syndrome conditions, which 
promotes endothelial dysfunction through NO quenching and eNOS uncoupling, and further 
endothelial dysfunction via progressive loss of NO bioavailability and superoxide production 
from eNOS. Feeding Yucatan miniature swine a 46% fat diet for 24 weeks has shown to increase 
penile thiobarbituric acid reactive substances (TBARS) and decrease the penile eNOS 
dimer:monomer ratio, demonstrating an association between an enhanced oxidative burden in the 
penis and eNOS uncoupling (144). NADPH oxidase induced eNOS uncoupling has been 
demonstrated in hypertension, where aortas of mice made hypertensive by deoxycorticosterone 
acetate-salt (DOCA-salt) exhibit depleted BH4 levels and increased eNOS derived superoxide 
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production, while  p47
phox-/-
 mice maintain BH4 levels and resist the upregulation of eNOS 
derived superoxide production associated with DOCA-salt hypertension (100). Furthermore, 
LDLR
-/-
 mice fed a hypercholesterolemic diet demonstrate a decreased cavernosal 
dimer:monomer ratio, while drinking water supplementation of apocynin restores the voltage 
dependent erectile response and the cavernosal eNOS dimer:monomer ratio (138). While we 
cannot be certain that NADPH oxidase induced eNOS uncoupling was the predominant 
mechanism promoting erectile dysfunction in response to the 12 week Western diet, NADPH 
oxidase inhibition with apocynin and BH4 stimulation with sepiapterin both augmented the 
voltage dependent erectile response to a similar degree. It should be noted that sepiapterin 
stimulates intracellular BH4 production, which may act as an antioxidant (36). Thus, in the 
absence of NOS dimer:monomer measurements, we cannot be certain that the reversal of ED 
with sepiapterin treatment is driven by enhanced NOS coupling rather than oxidant scavenging. 
 Contrary to the voltage dependent erectile response, sepiapterin treatment did not 
improve coronary artery endothelial dysfunction in the Western diet-sedentary rats. 10 µM 
sepiapterin treatment has previously restored endothelial function in aortic segments of ApoE
-/-
 
mice (92). Furthermore, oral administration of sepiapterin has been found to augment left 
ventricular function in STZ-induced diabetic mice (182), while intravenous administration of 
sepiapterin restores the cardioprotective effect of ischemic preconditioning that is completely 
blocked by severely hyperglycemic conditions (183). However, investigations on the effect of 
sepiapterin treatment specifically on coronary artery endothelial function has been limited. 100 
µM sepiapterin has previously been found to attenuate endothelial dependent vasorelaxation 
responses in canine middle cerebral arteries (184) and rabbit aortas (38), which agrees with the 
findings of the present study in which 10 µM sepiapterin attenuated ACh-stimulated 
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vasorelaxation in coronary artery segments of control diet-sedentary rats. It has previously been 
suggested that sepiapterin supplementation to normally functional eNOS could stimulate eNOS-
dependent superoxide generation, resulting in potential for attenuation of endothelial function 
(185). Additionally, the hypothesis of NADPH oxidase induced eNOS uncoupling suggests that 
NADPH oxidase activity is increased prior to any depletion of BH4 and resultant eNOS 
uncoupling (186). The Western diet used in the present study has previously been demonstrated 
to induce erectile dysfunction more rapidly than coronary artery endothelial dysfunction (187).  
Thus, it is probable that NADPH oxidase activity is also increased in the cavernosum prior to the 
LAD coronary artery. The findings addressed in specific aim 1 suggest that 12 weeks of 
exposure to the Western diet represents a very early time point in development of CAD in this rat 
model. These Western diet-sedentary rats demonstrated mild elevations in adiposity and blood 
glucose levels, with no substantial alterations in blood lipids or insulin sensitivity. Thus, it is 
possible that prolonging the dietary intervention may produce a situation similar to that in the 
penis, where functionality is augmented by either apocynin or sepiapterin treatment, as prior 
studies demonstrating increased vasoprotection or cardioprotection with sepiapterin treatment 
have utilized overtly hypercholesterolemic, hyperglycemic, or diabetic models (92, 182, 183). 
This study is in agreement with prior investigations, where apocynin has been shown to reverse 
endothelial dysfunction in coronary arteries of insulin resistant obese Zucker rats (188), type II 
diabetic mice (189), and high-fat diet induced obese mice (180). This study demonstrates that 
NADPH oxidase is an important mechanism of early coronary artery endothelial dysfunction, 
where endothelial function does not appear to be impaired due to attenuated BH4 availability.  
 The potential cardioprotective benefits of aerobic exercise are well documented (46).  
However, investigations on the impact of exercise interventions on erectile function are rather 
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limited. Obese men with ED who received lifestyle advice regarding diet and physical activity 
have reported improved erectile function (123), while treadmill exercise plus caloric restriction 
has been shown to improve erectile function in aging and hypertensive rats (190). Additionally, 
physical activity has been shown to augment the efficacy of phosphodiesterase 5 inhibition on 
ED reversal (191). There are previous implications for a protective effect of exercise through 
eNOS coupling, as treadmill exercise of pigs has shown to preserve the cavernosal eNOS 
dimer:monomer ratio that is attenuated in response to a hypercholesterolemic diet (144). 
Interestingly, a similar intervention has proven to preserve coronary artery endothelial function 
through a NO-mediated mechanism in this model (156). Importantly, exercise has shown to 
improve endothelial function in internal mammary artery segments and attenuate NADPH 
oxidase subunit expression in CAD patients (112). Similar to the present study, the apocynin-
induced augmentation of coronary artery endothelial function in high-fat diet fed mice is lost 
with the addition of voluntary wheel running (180). Aerobic interval training may be a 
particularly advantageous mode of intervention in the metabolic syndrome. Interval training 
protocols similar to that utilized in the present study have been shown to substantially augment 
flow-mediated dilation and aerobic capacity in human metabolic syndrome patients (47), heart 
failure patients (48), and CAD patients (192), as well as rodents bred to have a low aerobic 
capacity (49). In the present study, we demonstrate that aerobic interval training prevents 
Western diet-associated erectile dysfunction and coronary artery endothelial dysfunction.  
 Addressing specific aim 3, we investigated the impact of increasing body mass index on 
extracellular reactive oxygen species production and microvascular endothelial function. 
Subjects in the highest tertile of BMI demonstrated significantly elevated levels of combined 
H2O2 and superoxide production (ROS production). Remarkably, ROS detected in the presence 
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of apocynin was not different in the highest BMI tertile compared to the lowest BMI tertile. This 
finding suggests that the elevation in detectable extracellular ROS associated with high BMI was 
completely due to elevated NADPH oxidase activity that was inhibitable by apocynin.  In 
addition to elevated ROS production, subjects in the highest BMI tertile also demonstrated 
impaired microvascular endothelial function relative to both other tertiles. Similar to both 
erectile function and coronary artery endothelial function, impaired microvascular endothelial 
function in the peripheral vasculature was improved by NADPH oxidase inhibition with 
apocynin. Preliminary data suggests that an 8-week aerobic interval training intervention may 
reverse microvascular endothelial dysfunction in the highest BMI tertile. However, the exercise 
intervention does not appear to alter extracellular ROS production in the highest BMI tertile, 
suggesting that any improvements in microvascular endothelial function associated with exercise 
training are likely due to mechanisms other than ROS production.  
 A multitude of studies have utilized microdialysis to detect reactive oxygen species in 
rodent brain in various models of neurological disease or conditions of environmental stress 
(193-197). The vast majority of these studies have utilized perfusion of salicylate, which reacts 
with the hydroxyl radical to form 2,3-dihydroxybenozoate which is detectable with high 
performance liquid chromatography or gas-chromatography/mass-spectroscopy (194-197). 
Fewer investigations have utilized microdialysis perfusion of an electron spin resonance trap to 
detect non-specific ROS (193, 195). Notably, gp91
phox
 knockout has been shown to prevent 
lipopolysaccharide-induced ROS production in the brain (193), suggesting that NADPH oxidase 
is a prominent source of septic shock associated ROS production. Fewer studies have utilized 
microdialysis to detect ROS outside of the brain. Dihydroethidium and salmon DNA have been 
perfused to detect superoxide production in the renal medulla of rats (198, 199). Extracellular 
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superoxide production in the renal medulla elevated in the salt-sensitive hypertension model 
used, and was alleviated by seven days of apocynin perfusion of the renal medulla (199). Other 
prior investigations have utilized microdialysis to measure ROS in the extracellular fluid of 
skeletal muscle (200-205). These investigations have focused on measuring O2
·-
 release from 
contracting skeletal muscle, utilizing perfusion of cytochrome c and analysis of reduced 
cytochrome c as an indicator of O2
·-
 production. The majority of these investigations have 
utilized microdialysis in the gastrocnemius of anesthetized rodents (200, 202-205), while 
Hellsten et al. performed microdialysis in the vastus lateralis of physically active, healthy 
humans (201). Cytochrome c can be reduced by the hydroxyl radical or nitric oxide (50) and can 
be oxidized by peroxynitrite (206). The amplex ultrared method utilized in the present study 
offers several advantages in that measurements can be made simply with a portable fluorometer 
as opposed to chromatography based methods, there is no need to perfuse DNA, and there is no 
potential for increased fluorometric signal induced by nitric oxide. This study is the first to 
document increased in vivo extracellular ROS production in a human pathological state.  
 NADPH oxidase activity, p22
phox
, p47
phox
, and p67
phox
 expression have been shown to be 
elevated in internal mammary arteries of human type II diabetic patients (31), and coronary 
artery segments of human CAD patients (32), compared to non-diabetic patients, and patients 
without CAD, respectively. Additionally, p67
phox
 mRNA expression is elevated in saphenous 
veins of heart failure patients undergoing a coronary artery bypass graft. Similar to the present 
study, treatment with apocynin has been shown to improve nitric oxide mediated vasodilation 
and attenuated ROS production in small arteries removed from visceral adipose tissue of obese 
patients undergoing bariatric surgery (207). Silver et al have demonstrated a positive association 
between human vein endothelial cell p47
phox
 expression and both BMI and adiposity (208). 
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Induction of NADPH oxidase activity with increasing adiposity is likely complex and 
multifactorial. Treatment of cultured smooth muscle cells with either angiotensin II (209) or 
leptin (210) stimulates NADPH oxidase activity. Likewise, incubation with the inflammatory 
adipokine visfatin stimulates NADPH oxidase activity in endothelial cells and impairs coronary 
artery endothelium dependent dilation (211). Three days of intraperitoneal injection of C-reactive 
protein (CRP) induces an increase in aortic p47
phox
 membrane translocation, while injection or 
isolated vessel incubation with CRP impair mesenteric artery ACh-stimulated vasorelaxation 
(212). Similarly, three days of intraperitoneal injection of TNF-α induces an increase in p22phox 
and p40
phox
 mRNA expression (188). Thus, NADPH oxidase induced endothelial dysfunction 
associated with increased BMI and adiposity is likely mediated in part through the inflammatory 
cascade, while previous findings of increased NADPH oxidase activity or subunit expression in 
obesity associated pathological states are congruent with the findings of the present study.  
 Previous studies suggest that aerobic exercise reverses endothelial dysfunction through an 
attenuation of NADPH oxidase (107-109, 112, 113). The findings of the present study suggest 
that NADPH oxidase inhibition reverses microvascular endothelial dysfunction in the highest 
BMI tertile prior to exercise training, while having no effect following exercise training. Due to 
the low statistical power, the exercise training results of the present study must be interpreted 
with extreme caution. There was a large, positive effect-size of exercise on ACh-stimulated 
blood flow in the highest BMI tertile. However, there was also large, positive effect-size of 
exercise on SNP-stimulated blood flow in the highest BMI tertile. Thus, any apparent reversal of 
microvascular endothelial dysfunction by exercise training may be due to improved signaling of 
the cGMP pathway rather than improved capacity for NO production. There was a small effect-
size of exercise training on decreased ROS production in the highest BMI tertile, suggesting that 
87 
 
the 8-week exercise intervention does not alter ROS production, and likely does not alter 
NADPH oxidase activity itself. There was a large effect-size for a post-exercise training increase 
in non-apocynin inhibitable ROS production. This finding suggests that sources of extracellular 
ROS other than NADPH oxidase are elevated following the exercise intervention. Various 
exercise conditions have increased xanthine oxidase activity in rodent muscle (205, 213-215), 
indicating that the contribution of xanthine oxidase to extracellular ROS may increase with 
exercise training. Aside from redox regulation, exercise training may increase eNOS activity via 
increased HSP-90 association (111) or increased Ser
1177
 phosphorylation (106, 216, 217), which 
may be independent of oxidative stress.  
 In summary, these studies demonstrate that NADPH oxidase is a common mechanistic 
link between erectile dysfunction and coronary artery endothelial dysfunction in rats fed a high-
fat high-sucrose diet, and peripheral endothelial dysfunction in a high BMI human population. In 
the face of a worldwide obesity epidemic, novel approaches to treatment and prevention of CAD 
are increasingly necessary. These studies demonstrate that erectile dysfunction precedes the 
development of CAD in response to a Western diet, which supports the notion that ED may be an 
early marker of cardiovascular risk (174-177). Several studies have further suggested that 
peripheral endothelial function can be used for cardiovascular risk assessment (218-221). Access 
to human penile tissue for mechanistic studies of erectile function is extremely limited. However, 
peripheral skeletal muscle beds provide a dense microvascular network where invasive studies 
conducted under local anesthesia provide a vascular bed in which mechanistic studies can be 
conducted in humans that may be predictive of coronary vascular function. These studies 
describe a novel method by which extracellular ROS production can be measured alongside 
assessment of microvascular endothelial function, and further allowing for localized 
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pharmacological manipulation. Interestingly, the Western diet-sedentary rats and the highest 
BMI tertile of humans demonstrated impaired endothelial function in the absence of substantial 
elevations in insulin resistance or any elevations in blood lipid profiles. These blood results 
indicate that investigation of peripheral endothelial function may supersede the traditional blood 
markers used for cardiovascular risk assessment. These combined findings further underscore the 
feasibility of potential therapeutic approaches aimed at treatment of ED and peripheral 
endothelial dysfunction and prevention of CAD development. These studies further demonstrate 
prevention of erectile dysfunction and CAD development with aerobic interval training in rats, 
while preliminary data suggest that aerobic interval training may reverse peripheral endothelial 
dysfunction in humans, providing a potentially practical means of decreasing risk of 
cardiovascular disease. 
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